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Management of childhood obesity and its related health risks consume more and more 
time of the health professionals. This has led to a challenge for pediatric health care  
in the field of prevention and treatment of this growing health burden. 
The term obesity refers to an excess of adipose tissue or body fat (1). Methods for  
an accurate and reliable measurement of excess body fat, such as underwater weighing, 
magnetic resonance imaging or dual energy X-ray absorptiometry, are expensive,  
time consuming and impractical in general clinical practice (1). Therefore, the body mass 
index (BMI = weight in kg/(height in m)2, based on the reliable and easily obtainable 
measurements of body weight and height, has been proposed to define childhood 
obesity. The adult cut-off values of BMI for overweight and obesity are 25 and 30 kg/m2, 
respectively, and are related to increased risk for morbidity and mortality (2). However,  
in children these cut-off values are age- and gender dependent. Therefore the working 
group on childhood obesity of the International Obesity Task Force (IOTF) determined  
cut-off values for overweight and obesity in children based on 6 large growth studies 
(3). Using the standard definition for obesity from the 2004 IOTF report, the worldwide 
prevalence of children with obesity aged 5-17 years was estimated at 2-3% (4).  
This worldwide estimation is comparable with the 2003 childhood obesity prevalence rate 
of the Fourth National Growth Study in the Netherlands (5). Of growing concern in this 
respect are the results of the latest national growth study in the Netherlands (2010),  
in which the trend of increasing weight is still continuing, whereas the historically ongoing 
trend to increase height in Dutch children appears to have come to an end (Schonbeck  
et al, in preparation).
The prevalence rate of childhood obesity is influenced by several factors, including 
socioeconomic status (SES), ethnicity and gender. In industrialized countries an inverse 
association between SES and the prevalence rate of childhood obesity has been reported 
(6). In developing countries overweight is more prevalent in children with higher SES, 
although there are indications for a shift towards the poor (4;7). Differences in obesity 
prevalence rates are present also between ethnic groups within a country, with the highest 
prevalence rate found among children of Turkish and Maroccan origin in the Netherlands 
(8). In general, the prevalence of obesity tends to be higher in girls compared to boys.  
In the 1997 nation-wide growth study in the Netherlands the prevalence of obesity in girls 
was 3.3% compared to 2.6% in boys (5).
Our modern lifestyle has been termed the ‘toxic environment’, as it promotes high-energy 
intake by calorie-dense foods and discourages energy expenditure due to changes in 
means of transportation and leisure time activities. Also the size of food portions has 
increased over the years and the introduction of sweetened soft drinks has not been 
helpful either in keeping the body weight between normal boundaries. It has been 
estimated that each additional serving of sugared soft drinks leads to a 0.24 unit increase 
in BMI and an increased odds of 1.6 for developing overweight (9).
The current recommendation for treatment of obesity in children is a multidisciplinary 
lifestyle intervention with parental involvement (10). For obese adolescents one can 
consider adding a registered drug to the lifestyle intervention, although with caution and 
under strict follow-up. These recommendations are based on a Cochrane review, 
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in which 64 studies (54 lifestyle intervention studies and 10 on drug treatment) were 
included. However, information on long-term outcome (follow-up period of ≥ 6 months 
after treatment) of obesity treatment in children was limited and in the Cochrane review it 
was advised to study the efficacy of such approach in a long-term randomized clinical trial 
design. Also high quality research that considers psychosocial determinants of successful 
lifestyle interventions are needed to improve the clinician-family interaction (11).
Childhood obesity has a major impact on somatic as well as psychosocial health.  
Although most obese children will not experience the complications of their excess body 
weight during childhood, proof of the metabolic consequences may be already evident 
during those years (12). In fact, over the past few years there are only a few organ systems 
reported not to be affected by adiposity in children (4;12-14). Adolescent obesity is not 
only an independent predictor for adult obesity (15), but there is also evidence that  
the BMI during these years is a stronger predictor for adult morbidity than adult BMI (12). 
Indeed, the epidemic proportions of childhood obesity suggest that without firm actions 
in the prevention and treatment of obese children, the health and social consequences  
will be substantial and long-lasting (12).
Rationale for this thesis
In this thesis the effect of a family-based multidisciplinary cognitive behavioral treatment 
compared to standard care on obesity and associated complications is evaluated. 
The effect evaluation of the treatment will be focused on changes in:
 • total obesity, defined by the standard deviation score of body mass index;
 • abdominal obesity, defined by the standard deviation score of the waist circumference;
 • physical fitness, defined by maximal oxygen uptake;
 • glucose homeostasis and inflammatory state;
 • pre- and postprandial responses of the gastrointestinal hormones ghrelin,  
PYY and GLP-1; and
 • Health Related Quality of Life, both by child and parent report.
Subsequently, the metabolic consequences of childhood obesity on increased health risk 
are addressed. A model for predicting increased insulin resistance is developed, using the 
individual parameters of the Metabolic Syndrome, taking into consideration the different 
impact of the standardized components of the MS. 
Outline of this thesis
In chapter 2 the protocol description is provided of the studies discussed in this thesis, 
as well as an elaborate description of the family-based multidisciplinary cognitive 
behavioral treatment provided to the obese children. The effect of this lifestyle 
intervention compared to standard care on both total and central adiposity, as well as 
metabolic parameters, inflammatory state and physical fitness is described in chapter 3. 
Chapter 4 reports on the treatment effect on the pre- and postprandial responses of several 
gastrointestinal hormones (ghrelin, PYY, GLP-1) related to appetite regulation in the obese 
children. The effect of obesity and our lifestyle intervention on Health Related Quality of 
Life is presented in chapter 5. Shortcomings of the definition of the Metabolic Syndrome 
in its current dichotomous form and an alternative method to include the individual 
components of this syndrome for predicting insulin resistance are described in chapter 6. 
Finally, a brief overview of the major findings and limitations of the work presented in this 
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A B s t R AC t
Background
The prevalence of childhood obesity has increased rapidly during the last three decades 
in the Netherlands. It is assumed that mainly environmental factors have contributed 
to this trend. Parental overweight and low social economic status are risk factors for 
childhood obesity. Childhood obesity affects self-esteem and has negative consequences 
on cognitive and social development. Obese children tend to become obese adults, 
which increases the risk for developing cardiovascular complications, type 2 diabetes 
mellitus, and psychosocial problems. Additionally, the secretion of several gastrointestinal 
hormones, responsible for appetite and food intake, is impaired in obese subjects.  
Weight reduction through lifestyle changes in order to change health risks is, until now, 
suggested as the preferred treatment for childhood obesity. 
The objective of this study is the effect evaluation of a family-based cognitive behavioral 
multidisciplinary lifestyle treatment. The intervention aims to establish long-term 
weight reduction and stabilization, reduction of obesity-related health consequences 
and improvement of self-image by change of lifestyle and learning cognitive behavioral 
techniques.
study design/ Methods
In this randomized clinical trial newly presented children with obesity (8-17 years old) 
are divided, by randomization, in an intervention and control group, both consisting of 
40 obese children. The intervention is carried out in groups of 8-11 children, and consists 
of respectively 7 and 5 separate group meetings for the children and their parents and 
1 joint group meeting of 2½ hours. Main topics are education on nutrition, self-control 
techniques, social skills, physical activity and improvement of self-esteem. The control 
group is given advice on physical activity and nutrition. For normal data comparison,  
data were collected of 40 normal-weight children, 8-17 years old.
Discussion
Because of the increasing prevalence of childhood obesity and the impact on the 
individual as well as on society, prevention and treatment of obesity in children is of great 
importance. For evaluation of short- and long-term effects of the treatment, measurements 
are taken before and after 3 months of treatment, and after 12 and 24 months follow-up. 
During these visits clinical and biochemical data are determined, cardiovascular fitness 
tests are performed and quality of life questionnaires are completed.
trial registration
International Standard Randomised Controlled Trial Number Register ISRCTN36146436
The effect of family-based 
multidisciplinary cognitive behavioral 
treatment in children with obesity:  




The effect of family-based multidisciplinary cognitive behavioral 
treatment in children with obesity: study protocol for  
a randomized controlled trial
2
Background
During the last three decades the prevalence of childhood obesity has increased dramatically 
in western countries, including the Netherlands [1-7]. In the Netherlands the highest 
prevalence of obesity is found in children and adolescents of Turkish and Moroccan origin 
[8,9]. Other risk factors for developing obesity include parental overweight or obesity,  
low socio-economic status, and low parental education level [4,9-11]. 
The adult cut-off values of BMI for overweight and obesity are 25 and 30 kg/m2, 
respectively, and are related to increased risk for morbidity and mortality [1]. However,  
in children BMI is age and gender dependent, so that BMI is usually expressed as standard 
deviation score (SDS). The working group on childhood obesity of the International Obesity 
Task Force (IOTF) determined cut-off lines for overweight and obesity in children based on 
the BMI-SDS that ended at 25 and 30 kg/m2, respectively, at 18 years of age, obtained from 
6 large growth studies carried out before the obesity epidemic [2].
The rapidly increasing prevalence of childhood obesity seen during the last few decades,  
is mostly the result of an increased food consumption and a change from a more physically 
active lifestyle to a more sedentary one. Studies indicate that 50% of the children  
and 80% of the adolescents with obesity will remain obese in their adult life [12-14].  
In adults obesity is associated with a higher risk for developing type 2 diabetes mellitus 
and cardiovascular disease [15-19] and in children obesity is associated with increased 
prevalence of hypertension, dyslipidemia and impaired glucose metabolism [20-27]. 
The clustering of these risk factors is called the Metabolic Syndrome (MS) also known as 
Syndrome X or the Insulin Resistance Syndrome [28]. 
For adults various definitions of the MS have been described. The most commonly  
used definitions are those proposed by the World Health Organization [29], the National 
Cholesterol Education Program’s Adult Treatment Panel III [30] and the International 
Diabetes Federation [31]. These three definitions concur for the essential components 
(central obesity, hypertension, impaired HDL-cholesterol (HDL), triglycerides (TG)  
and impaired glucose tolerance). For the pediatric age group several definitions have 
been proposed, but modifications of the three mentioned definitions for adults are used 
most often [32-38]. However, consensus on the cut-off levels of the components of the MS 
for pediatric patients is even more difficult to obtain than for adult patients. One of the 
reasons may be that in children these cut-off levels are not only influenced by gender and 
ethnicity, but also by age and pubertal stage. In order to get better insight in the impact  
of the MS in the pediatric age group an internationally accepted definition is necessary. 
Moreover, it has become clear that the adipose tissue is an endocrine organ [39,40]. It does 
not just serve as a fat deposit but it secretes a wide range of hormones and other proteins. 
Obesity represents a chronic state of inflammation, with increased levels of the C-reactive 
protein (CRP) [41-43] and decreased levels of adiponectin [44-47]. This chronic state  
of inflammation may be the common soil for the development of insulin resistance and 
cardiovascular disease. It has been shown that obese subjects, both adults and children, 
have significantly lower levels of adiponectin compared to normal weight individuals  
[44-49]. After clinically relevant weight loss, levels of adiponectin increase accompanied  
by improvement of insulin sensitivity [48,50]. 
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The insulin secretion after consumption of nutrients is regulated by neural and hormonal 
signals from the gut and the intestine [51,52]. The gastrointestinal tract is the largest 
endocrine organ responsible for the regulation and signalling response of food intake to 
the brain [51,52]. Gastrointestinal hormones are the key mediators in these processes of 
food intake regulation. Several gastrointestinal hormones are impaired in obese persons, 
including ghrelin [51-56], peptide YY (PYY) [51,52,57-59] and glucagon-like peptide 1 
(GLP-1) [52,60-64]. In contrast to many other endocrine hormones, gut hormones have 
predominantly short-term actions [52]. 
Ghrelin is a 28 amino acid peptide released from X/A-like cells of the gastric oxyntic glands, 
and in lower amounts from the small intestine and the hypothalamus [51-53]. Ghrelin is  
the only gut hormone known to increase food intake. An inverse association is found 
between circulating levels of ghrelin and BMI, so that obese subjects have lower levels  
of ghrelin [51-54,65-67]. There is still much uncertainty about the effect of weight loss 
on the ghrelin response. Some studies found increased ghrelin levels after weight lost 
[51,52,56], but others could not confirm this finding [56,68].
Both PYY and GLP-1 are synthesised and released after food intake by L-cells of the distal 
gut [51,52,57,59,69]. For fasting PYY an inverse association is found with BMI, in both adults 
[51,52] and children [51,52,57,59], whereas no significant association with body weight was 
found for fasting GLP-1 [52]. Postprandial levels of both hormones [51,52,59] [52,60-64,70] 
are found to be blunted in obese individuals, and weight loss seems to affect this [59] 
[52,61,71]. However, the mechanisms underlying the synthesis and release of especially 
GLP-1 from L-cells are largely unknown. 
Besides these physiological changes, obesity also has a huge impact on the psychosocial 
well-being of the child with obesity [7,72-75]. Obesity is often associated with feeling 
ugly, lazy, stupid and with low self-control, which results in a negative self-image and, 
consequently, social isolation of the obese child. This social isolation can aggravate  
the obesity because the child can use eating as a coping strategy [72,76]. 
The question which intervention is most effective in treating both the physiological  
and psychological aspects of childhood obesity has not yet been definitely answered. 
The recently published update of the Cochrane review ‘Interventions for treating obesity 
in children’ [77] included 54 randomized clinical trials on lifestyle interventions, with 36 
focusing on (family-based) behaviorally orientated treatment programs. From the 54 
included studies on lifestyle interventions, 40 interventions lasted longer than 6 months,  
6 of which up to one year and 4 lasting 2 years. The aim of this Cochrane review was  
to ascertain which intervention is most effective in the treatment of childhood obesity. 
However, study design, duration of follow up and outcome measures differed significantly 
in the included studies and it was only possible to give a recommendation. The results of 
the meta-analysis showed that for the treatment of childhood obesity a behavioral lifestyle 
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The intensity of the intervention appears important for the efficacy, because  
an observational study, including 129 treatment centers in Germany, Austria and 
Switzerland [78] demonstrated a significantly positive association between BMI-SDS 
reduction and intensity of the intervention after 24 months follow-up, while there was  
no association with duration. These authors also found a reduced BMI-SDS in nearly half  
of the children after 24 months of follow-up, with 25% of them showing a reduction  
of >0.5 SDS, which has been demonstrated to be clinically relevant [79-81]. Younger 
children (< 12 years) showed significantly higher success rates at 24 months’ follow-up. 
A major problem with lifestyle intervention programs is the high percentage of incomplete 
follow-up data due to drop-out or lack of documentation, which makes it very difficult  
to reliably assess the effectiveness of the treatment. Therefore, in order to accomplish  
long-term weight loss and health improvement, future research should focus on 
adequately powered long-term (> 6 months) evaluation of lifestyle interventions,  
with psychosocial determinants for behavioral change and parental involvement.
Objective
The primary aim of this study is the effect evaluation of a family-based multidisciplinary 
cognitive behavioral treatment on obesity (expressed as body mass index (BMI)-
standard deviation score (SDS)) compared to standard care (advice on increased physical 
activity and dietary changes) in children with obesity. The secondary aim of the study 
is to investigate the effect of this treatment on changes in waist circumference, insulin 
sensitivity, inflammation, secretion of gastrointestinal hormones and changes in physical 
fitness and quality of life, compared to standard care. Furthermore, we aim at assessing  
the effects of possible predictive factors for the long-term response to treatment. 
Main research question
1. Do children (8-17 yr.) with obesity show a significant decrease (> 0.5) in BMI-SDS  
(as defined by Cole et al. [82]) after 3 months of intensive treatment compared to 
children who were given advice on increased physical activity and dietary changes?
secondary research questions 
1. Do children with obesity have significantly more beneficial effect of 3 months  
intensive treatment compared to standard care on changes in waist circumference, 
insulin sensitivity, secretion of gastrointestinal hormones, cardiovascular fitness  
and quality of life?
2. Will the hypothesized beneficial effects of 3 months intensive treatment in children 
with obesity persist after 12 and 24 months of follow-up? 
3. Are ethnic background of the children, the level of parental education, or the socio-
economic status predictive variables for the degree of obesity in these children,  
and for the success of treatment?
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M e t H O D s / D e s i G n
Design
The study design is a randomized clinical trial for 2 years.
Newly presented children with obesity referred to the pediatrician are physically examined. 
If a child meets the inclusion criteria of the study, the pediatrician informs the parents  
and the child about the study. After written informed consent, the children are randomized 
to the intervention and control group, after stratification for gender and ethnicity, in two 
age groups, one from 8 to 12 years and one from 13 to 17 years. An experienced assistant 
blinded for the study design measures weight and height.
Ethnicity is determined according to self-reports by the parents. For this analysis children 
are classified as ‘Northern European’ if both parents report the Northern European 
ethnicity, and ‘Others’ if one or both parents report another ethnicity. 
To enable comparison of the participants’ anthropometric and biochemical data with 
proper reference data, an age-matched sample of healthy children with normal weight  
is recruited from the youth health services (Jeugd GGD Haaglanden). 
Measurements are taken before (t=0 months) and after (t=3 months) the treatment of  
the intervention group and after a follow-up period of 12 months. For long-term purposes 
the intervention group is also evaluated after 24 months. The control group is offered  
the same treatment regimen after 12 months.
The normal weight control group is measured once.
eligibility criteria
Children with obesity (according to Cole et al. [2]) aged 8-17 years, living in the Hague 
and in the area around the Hague and referred to a pediatrician, are invited to participate. 
Reasons for referral are overweight or obesity, and increased risk of co-morbidity  
(e.g. hypertension, family history of diabetes mellitus and/or hypercholesterolemia  
and/or cardiovascular disease before the age of 55, Hindustani ethnicity). 
Potential participants are excluded if their knowledge of the Dutch language, intelligence 
or social skills are insufficient to participate in the group. Other exclusion criteria are use 
of medication that might have an effect on weight loss, medical co-morbidities that could 
affect participation, or previous enrollment in another cognitive behavioral treatment 
program with the focus on reducing obesity.
Recruitment
During the first pediatric consultation inclusion and exclusion criteria are checked. 
Motivation and expectations of both children and parents are evaluated; e.g. it is checked 
whether they understand the reason to participate and know why it is important to reduce 
body weight, and whether their expectations of the treatment are realistic. Pros and cons 
of treatment versus no treatment are discussed, as well as alternative treatment options.  
If the children do not fulfill the inclusion or exclusion criteria an alternative treatment  
is offered to the parents and the child. 
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Randomization
For the children who meet the inclusion criteria the parents and the children are asked  
to sign the informed consent. Following informed consent of all participating children and 
parents the children are stratified by gender and ethnicity (‘North European’ and ‘Other’) 
and randomized to the intervention or control group according to coin-tossing. In order  
to obtain a similar size of the intervention and control groups, blocked randomization  
is applied with an allocation ratio of 1:1. Randomization is carried out by a member of  
the team who does not take part in the treatment. Both the intervention and control 
groups consist of 40 children per group. The children in the intervention group are divided 
into smaller groups of 10, depending on the child’s age. After randomization, children 
receive a randomization code. All data are analyzed according to this randomization code. 
The key to the source data is only known by the researcher and research coordinator.  
The researcher is familiar with the study procedure, is trained prior to the study and 
collects all data for this study. The normal-weight control group consists of 40 children, 
8-17 years, with normal body weight.
ethic Aspects
This study is conducted in agreement with the ‘Declaration of Helsinki’. 
Approval is obtained from the regional medical ethical committee Zuid-West Holland.  
All parents and children gave their written informed consent.
t R e At M e n t
treatment intervention group
The cognitive behavioral treatment program consists of an intensive phase of  
three months, followed by booster sessions for a total period of two years. During the 
intensive phase of the program the intervention group is offered 7 group meetings of  
2½ hour and the parents are offered 5 separate parent meetings and 1 meeting together 
with the children. 
The primary goal of the cognitive behavioral treatment is recognition and 
acknowledgement of the obesity and learning a healthy lifestyle. This is accomplished  
by health education and by teaching cognitive behavioral techniques.
The secondary goals of the treatment program are a reduction of 10% of the body 
weight during the intensive phase of the treatment and a further reduction or at least 
maintenance of the reduced body weight.
A treatment period of at least two years is chosen because it will take time to adapt  
to a new lifestyle and the risk of relapse is considerable.
screening phase
During the screening phase the children with their parents are seen at two separate 
occasions individually by a dietitian, a child-physiotherapist, a child-psychologist and  
a social worker. In this way it is evaluated whether the timing of the treatment is 
appropriate, and whether there are individual family situations which could interfere  
with the treatment. Also causal factors of the obesity are discussed and opportunities  
to establish lifestyle changes are mapped out.
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Dietitian: During the first consultation the weight and diet history of the child and their 
family are verified. Also their general knowledge of nutrition and their expectations  
of the role of a dietitian in helping them to reduce body weight are discussed. At the end 
of the session the child is asked to make a diet report of two weekdays and one weekend 
day. During the second session an evaluation of the diet reports is made and information 
is provided about nutrition and healthy eating behavior according to the traffic light 
nutritional list. The traffic light nutritional list [83] is divided into several main food groups 
(e.g. fruits, vegetables, grains, milk and other dairy products, meat, fish, and others).  
Foods within each group are color coded according to the calorie density per average 
serving and Dutch standards for health nutrition. The colors, similarly to those of a traffic 
light, are green for “go”, orange for “approach with caution”, and red for “stop”. The goal 
of the use of the traffic light nutritional list is not only to reduce calorie intake but more 
importantly to learn healthy eating behavior. At the end of the second session achievable 
treatment goals are formulated. 
Physiotherapist: Current physical activity level and sedentary behavior of the child 
is reviewed. Energy intake versus energy expenditure is evaluated and visualized for  
the child by a computer program. With this computer program the child can choose  
a favorite product from a nutritional list and the program then shows the child the amount 
of time and intensity of physical activity that is necessary to burn the energy consumed. 
Also options to change or optimize physical and sedentary activities are debated. The child 
is advised how to find suitable exercise programs.
Psychologist: Most children with obesity do not have sufficient insight in how obesity 
develops and how to reduce body weight. The role of the child psychologist is to help  
the child not only to reduce weight by learning cognitive behavioral techniques, but also 
to deal with and accept their own body. 
For the success of the treatment the children must be motivated and able to change 
behavior. It is explained that the role of the parents during the treatment is that of  
‘the therapeutic helper’. The degree of suffering with regards to body image and the role  
of eating and obesity in the family are evaluated as well.
During the individual consultations by the child psychologist several questionnaires are 
asked to be filled; the ‘Dutch Eating Behavior Questionnaire’ (Nederlandse Vragenlijst 
Eetgedrag/ NVE) [84], the ‘Child Behavioral Checklist’ (CBCL) [85], the ‘Youth Self Report’ 
(YSR) [85], the ‘Teacher Report Form’ (TRF) [85] and the ‘Perceived Competence Scale for 
Children’ (CompetentieBelevenisSchaal voor Kinderen/ CBSK) [86].
Before the child starts with the group sessions individual treatment goals are written down 
in a contract. It is important that the goals are achievable to avoid disappointment.  
Also a buddy is chosen by the child who will help to achieve his or her goals.
treatment
Group treatment is a useful way to learn cognitive behavioral techniques especially  
if groups are limited to 8-10 participants. Children can learn from each other (modeling). 
Peer group support is especially important for the older children group (≥ 12 yrs). 
Before the first group session the children receive a treatment manual with the objectives 
and goals of the treatment and, per session, information about the topics discussed.  
To achieve successful treatment results it is important, at the beginning of the treatment, 
to focus more on the effort to change habits and the input of the participants and less  
on the weight reduction goals. This is accomplished by making the child aware of  
its own actions and way of living that has led to his or her obesity.
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Several cognitive behavioral techniques are learned (knowledge, skills and attitude) during 
the intensive phase of the treatment in order to maintain long-term lifestyle change and 
body weight reduction. The cognitive behavioral strategies are learned during six sessions 
of 2½ hours per session. Sessions are given biweekly. 
Each session contains the following components:
 • Determination of body weight
 • Homework discussion and evaluation 
 • Education
 • Physical activity 
 • Role playing
 • Discussing homework for next meeting
 • Set goals linked to educational topics of the session
Parental involvement
Not only the motivation to change the lifestyle of the children is important, but also  
the motivation of the parents. Parents must be willing to invest time in the treatment. 
Separate parallel parent group sessions (5 evenings) are offered by a dietitian and a social 
worker. In most cases parents do the shopping and food preparation, so for the treatment 
to be successful parental involvement and support is essential. 
The role of parents is that of ‘the therapeutic helper’ who gives positive feedback to their 
children and supports the child in a positive way. 
Parents should be a role model for their children, giving a good example through eating 
healthy food, increasing physical activity and decreasing sedentary activity.
Children’s Group sessions
educational topics in session 1
Most children with obesity have negative experiences with group activities. For example, 
they are often not included in social events or chosen last by peers during sport activities. 
Therefore, during the first session much time is spent in getting acquainted with each 
other. A good group bond is important for the effect of the treatment because peer 
support can be very helpful in the treatment of obese children. During this part of  
the session children give their individual motivation for participating.
The topic of the second part of this session is nutritional information and the balance 
between energy intake and energy expenditure. This is explained by using the symbol  
of a balance. Solutions to improve the misbalance are discussed. When the energy intake 
part of the balance is greater than the energy expenditure part, energy expenditure must 
be increased or energy intake must be decreased, or both.
educational topics in session 2
The main topic of the second session of the treatment phase is again information  
on healthy nutrition. Different categories of nutrition and quantities of each category 
linked to a healthy eating pattern are discussed. Children learn how to read product labels 
and to obtain information on misleading advertisement. They also discuss how to deal with 
meals (breakfast, lunch, diner, 2 healthy snacks), and how to make healthy choices and 
develop healthy eating habits (small bits, slow eating, eating at the family table, no other 
activities during eating). In games the educational topics are rehearsed and participants 
need to label products according to the traffic light method [83].
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educational topics in session 3
In this session self-control techniques to cope with difficult situations are taught.  
Children formulate and acknowledge difficult situations (e.g. birthday parties, holidays, 
lunch breaks at school, being at home alone). Problem solving alternatives are debated 
(e.g. to avoid a situation, doing something else, participate in a situation and eat less,  
or participate followed by extra exercise afterwards). The problem-solving alternatives  
are rehearsed with role-playing. 
Other psycho-educational topics reviewed during the third session are self-reward  
(when coping well with a difficult situation) and self-regulation situations (making  
a plan how to integrate healthy behavior in daily living). Stimulus control is also one of 
the psycho-educational topics of the third session (remove unhealthy stimuli at home, 
encourage healthy behavior, eat at the dinner table, reduction of environmental stimuli 
linked to eating).
educational topics in session 4
Most people associate obesity with being ugly, lazy or stupid which makes children with 
obesity often the subject of teasing by peers. The topics of the fourth session are therefore 
coping with teasing and being teased, how to deal with it and how to react with dignity. 
The children are explained that there are three coping strategies to deal with this situation; 
react angry (fight), walk away (flight) or deal with the situation (preferred strategy).  
Using role-playing the children are taught to react with a dignified, but powerful response. 
During this session the children are asked to think of someone in their environment  
who can help them during difficult situations or when they are teased.
educational topics in session 5
The focus of the fifth session is self-image. Most children with obesity have a low self-image 
and a low health-related quality of life. Not only other people associate obesity with being 
ugly, lazy or stupid, but the children also think likewise about themselves. It is difficult for 
them to mention positive things about themselves. Children are taught to take a positive 
look at themselves and name positive, nice things or characteristics about themselves  
and other children in the group.
educational topics in session 6
During the sixth session the children are given the opportunity to repeat topics discussed 
during the other sessions. Also cognitive strategies and relapse techniques are taught  
to maintain newly learned behavior. 
Parent Group sessions
session 1
Parents are given information on the treatment program of the children and what they can 
expect of their own group sessions. Information on healthy nutrition, product information, 
quantities, eating moments, eating locations, how to help their children (also when there 
are children in the family with a normal body weight) are discussed. Parents also receive 
advice on parenting styles to give strict rules but also manage the family in a pleasant way.
session 2
During the second session parents are taught how to support their children during 
the treatment and thereafter by acknowledging the child’s efforts and giving positive 
feedback. It is made clear to the parents that for the treatment to be a success, parental 
support is very important.
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session 3
Parenting styles are taught during the third session on how to set boundaries and how  
to limit the sometimes abnormal eating behavior of their child. 
session 4
During this session topics of the previous sessions are repeated, and questions relevant  
to the obesity subject are answered.
session 5
During the last separate parental group session a therapist discusses the role of all other 
family members with regard to the treatment in the family (e.g. are other family members 
supportive, how do they cope with the lifestyle changes?). 
Joint session
During the last session children and parents celebrate the end of the intensive period in 
a healthy way. Children are asked to make healthy snacks and in this way the children can 
bring into practice how to cope with a normally difficult situation. Games and activities are 
planned as well, so children and parents can bring into practice that festive parties can also 
be associated with fun and social interaction instead of the intake of food alone. 
follow-up
Booster sessions are a very important component of the treatment of children with obesity. 
In order to maintain the newly learned behavior booster sessions are necessary during the 
first two years. The child psychologist and the social worker organize the booster sessions. 
The topics that are repeated are: problem solving techniques and relapse prevention 
techniques. 
treatment Control group
The control group is given an initial physical activity and nutritional advice.  
After 12 months the children are offered the multidisciplinary treatment. During the  
12 months study period the children are seen at start, after 3 months and at the end  
of the period just before they start the treatment.
s t u Dy  P R O C e D u R e s
Medical examination
During the first visit to the pediatric clinic general information is collected concerning 
pregnancy (duration of gestation, smoking, hyperemesis, pre-eclampsy, medication, diabetes)  
and birth (position of the child during delivery, complications during delivery, birth weight, 
height, head circumference). Also information on motor and mental development  
(current educational level) of the child is collected. Furthermore, information on the highest 
accomplished educational degree and current work of the parents, as well as height, weight 
and activity level of the parents and other family members and the occurrence of diseases  
in the family is collected. 
At physical examination the occurrence of hirsutism, acanthosis nigricans and possible 
dysmorphic characteristics is evaluated. Pubertal development is recorded by the pediatrician 
according to Tanner [87]. Breast development in girls and genital development in boys is used 
for pubertal classification into two groups. Boys with genital stage 1 and girls with breast stage 
1 are classified as prepubertal, and boys and girls with stage 2-5 are classified as pubertal.
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Anthropometric parameters
Weight is measured to the nearest of 0.1 kg using an electronic scale (SECA 911,  
Vogel & Halke, Hamburg, Germany) and height to the nearest of 0.1 cm with a stadiometer 
(Holtain, limited, Crymych, Dyfed, Britain) in underwear and barefoot. The BMI is calculated 
as weight / height squared (kg/m2). Subjects are classified as obese using BMI gender-  
and age specific international cut-off levels developed by Cole et al. [2] BMI expressed  
as standard deviation score (SDS) for Dutch reference data [82] is used as the main 
outcome parameter. 
Waist circumference (WC, in cm) is measured with an anthropometric tape midway 
between the lower rib margin and the iliac crest at the end of gentle expiration. The waist 
to height ratio (WC/Ht) is calculated as WC/height, both measured in centimeters. 
Blood pressure measurements (Criton Dinamap, No. 8100) are performed in a relaxed 
sitting position, in duplicate; the last measurement is used for analyses.
Blood sample analysis
With the participant in the supine position, blood samples are taken by venipuncture  
after an overnight fast. Before blood sampling, the fasting state is verbally confirmed  
by the participant and the parent. Fasting blood samples are taken to determine glucose, 
insulin, C-peptide, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides,  
free fatty acids, free T4, TSH and inflammation parameters (CRP, adiponectin).
Mixed Meal tolerance test
The children are asked to consume at least an amount of 150g of carbohydrates three 
days prior to the mixed meal tolerance test and continue with their normal daily physical 
activities. The day before the test the children are asked not to consume any food or drinks 
after 10 pm, with the exception of tap water. 
On the morning of the mixed meal tolerance test the fasting state is verbally confirmed  
by the participant and the parents. An antecubital intravenous catheter is placed for  
blood sampling. Fasting blood samples are taken twice with an interval of 15 minutes  
(t=-15 and t=0). After the second fasting blood sample is taken, the participant receives  
a mixed meal bolus of 200 mL (Nutridrink Yoghurt Style, Nutricia, Zoetermeer,  
The Netherlands). The mixed meal bolus consists of 49% carbohydrates, 35% lipids and 
16% proteins. After the consumption of the mixed meal bolus, blood samples are taken 
two times with 15 minutes intervals (t=15 and t=30) and four times with 30 minutes 
interval (t=60, t=90, t=120 and t=150). Blood samples are analyzed and plasma glucose, 
plasma insulin and gut hormones (Ghrelin, GLP-1, PYY) are determined. In order to be able 
to analyze levels of the gut hormones GLP-1 and PYY it is necessary to add the enzyme 
dipeptidyl peptidase IV (DPPIV) to the tubes.
insulin Resistance and insulin sensitivity
An index for insulin resistance is calculated according to the Homeostasis Assessment 
Model for insulin resistance (HOMA-IR) formula: (fasting insulin (μU/mL) x fasting glucose 
(mmol/L)) / 22.5 [88]. 
Insulin sensitivity is calculated using the quantitative insulin-sensitivity check index 
(QUICKI) formula: 1/(log fasting insulin (mU/L)+log fasting glucose (mg/dl)) [89].
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Voluntary Maximal exercise test
The physical fitness of the children is determined by a voluntary maximum exercise test  
on a treadmill using breath-by-breath analysis and plots according to Wasserman [90].
The exercise test consists of three stages; a reference stage (2 minutes rest measurement 
prior to the exercise test), the test stage (the exercise test till voluntary exhaustion) and  
a recovery stage (2 minutes recovery measurement in rest after the exercise test). The test 
stage starts with a velocity of 4 km/h and an angle of 0% during 1 minute. Every minute 
the velocity is increased with 0.5 km/h and the angle with 2%, till voluntary exhaustion. 
During the test the participants are encouraged to exert a maximum effort. At the end of 
the test the children are asked to grade the level of exhaustion by using the Borg scale [91] 
and the reason to stop.
In adults a maximum effort is achieved when two of the following criteria are fulfilled:
 • The difference in heart rate between the last two stages was less than 5 beats  
per minute.
 • The difference in VO2 was less than 100 mL/min between the last two stages.
 • A Respiratory Exchange Ratio (RER) of > 1.0.
However, the first two criteria are not always found in adults and rarely in children. 
Therefore, in this study peak values are referred to instead of maximum values.  
Peak values are reached when the children look physically exhausted and a RER of > 1.0  
is accomplished. The physical fitness is calculated from the absolute peak value of oxygen 
uptake, standardized to age and gender (VO2peak-SDS). Yet the absolute peak oxygen 
uptake in obese can give an overestimation of the real physical fitness because of their 
increased body size [90]. For that reason also the peak oxygen uptake adjusted for body 
weight, age and gender (VO2peak-SDS-kg) is determined to establish a more realistic value 
for the physical fitness.
Health Related Quality of Life 
The health related Quality of Life (HRQOL) of the children is determined by the 
questionnaires DISABKIDS and KIDSCREEN [92]. The DISABKIDS and KIDSCREEN projects 
developed an instrument with a generic part (KIDSCREEN), and a chronic generic part 
(DISABKIDS). The KIDSCREEN part of the questionnaire is suitable for children aged 
between 8-18 years, and the DISABKIDS part for children aged between 4-18 years.  
The generic part of the questionnaire is used to compare children with a disease with 
healthy children. For this part only the child version is used. With respect to DISABKIDS, 
also the parental version is used, to compare the HRQOL reported by the child with  
the child’s HRQOL from the parents’ view. 
The KIDSCREEN contains 52 questions divided over 10 subscales of 3-7 items each.  
The DISABKIDS part of the questionnaire contains 37 questions divided over 6 subscales  
of 6-7 items each. Every question can be answered by choosing from 5 options: never, 
almost never/ seldom, average/ sometimes, quite often, always. The items are scored  
on a 5-point scale (0-4). Both parts are scored by summing the responses for the 52 and  
37 items, respectively, after adjustment for the negative items, and expressed as 
percentages between 0-100. A higher score reflects a better HRQOL.
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KIDSCREEN is used to compare the HRQOL of the children with obesity with a normal 
weight control group and DISABKIDS to compare the obese children in the intervention 
group with the children in the obese control group. The KIDSCREEN questionnaire has 
demonstrated a Cronbach α reliability coefficient ranging between .77 and .89 for all ten 
domains [92]. The Cronbach α reliability coefficient of the child version of the DISABKIDS 
ranges between .70 to.87 for children aged 8-12 years and between .77 to.90 for children 
aged 13-16 years [92]. A Cronbach α ≥0.7 is considered as good validity.
Other questionnaires used during the screening phase of the treatment 
 •  Dutch Eating Behavior Questionnaire (Nederlandse Vragenlijst Eetgedrag/ NVE):
The NVE [84] is administered during the screening phase. It consists of three subscales: 
Emotional Eating (13 items), External Eating (10 items), and Restrained Eating (10 items). 
The items are scored on a 3-point Likert-type scale ranging from never to very often.  
The items in the conditional format also have the response option not relevant.  
A high score reflects a specific eating behavior of the particular subscale.  
The NVE scales have been proven to provide good internal consistency, satisfactory 
factorial validity and dimensional stability [72,84].
To assess the child’s psychological and social adjustment three versions of the Child 
Behavior Checklist are asked to fill in. One version is filled in by the parents (Child Behavior 
Checklist), one by the child themselves (Youth Self Report) and one by a school teacher 
(Teacher Report Form):
 • Child Behavior Checklist (CBCL):
The Dutch version of the CBCL [85] is completed during the screening phase by  
the parents. The questionnaire includes 138 items and yields scores for total behavior 
problems, internalizing and externalizing behavior of their child. Also three scores for 
competence are determined (activity, social competence, school competence) 
 • Youth Self Report (YSR):
The children fill in the YSR [85] version of the CBCL during the screening phase to 
visualize the child’s own view on his or her internalizing and externalizing behavior. 
 • Teacher Report Form (TRF):
A school teacher of the child fills in the TRF [85] version of the CBCL in order to 
determine the internalizing and externalizing behavior of the child at school.
 • Perceived Competence Scale for Children (Competentie Belevings Schaal voor  
Kinderen/ CBSK): 
The CBSK [86] is used during the screening phase to determine the self-perception  
or self-concept of the child. The CBSC consists of 28 items and assesses the child’s  
self-perception in four different areas of perceived competence; cognitive ability, 
physical activity, peer relations, and general self-esteem. 
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type of Analysis
The analyses are performed by using the Statistical Package for Social Science SPSS,  
v. 17.0 for WINDOWS; SPSS Inc., Chicago, IL, USA) and the level of significance is set  
to <0.05, according to an intention-to-treat analysis. 
Data are checked for normality before analysis using descriptive statistics and histograms. 
Data are expressed as mean ± standard deviation (continuous variables) and as count  
and percentage (categorical variables), unless specified otherwise.
For the analysis of treatment effect between both obese study groups for continuous data, 
independent t-tests, (M)AN(C)OVA and mixed model for repeated measures are used per 
time point, adjusted for baseline values. Categorical data are analyzed with the Chi-square 
test for comparison between groups. In addition, paired t-tests, (M)AN(C)OVA and mixed 
model for repeated measures are used to compare the parameters within treatment 
groups over time. For predictive analysis linear and logistic regression analysis is used  
for continuous dependent variables and binomial variables, respectively.
Power Calculation
The sample size of a study was based on the power calculation for unpaired means  
with normal distribution and can be calculated by the following formula:
N1 = N2 = (z1-β + z1-α/2)
2 x ((σ1
2 + σ2
2) / (μ1 – μ2)
2)
In this study α = 0.05 and β = 0.20 is chosen, so z1-α/2 = 1.96 en z1-β = 0.84.
The results of an unpublished pilot study of the proposed treatment given to children 
with obesity in our hospital showed a clinically relevant difference of 0.6 BMI-SDS between 
intervention and control group, and the difference between post-treatment and baseline 
ranged between –2.85 and + 0.70. The difference between the means is therefore chosen 
as μ1 – μ2 = 0.6 and the estimated sigma, under normality assumption, will be 
3.55 / 4 = 0.89, so σ1
2 + σ2
2 = 1.58.
In the formula this determines a N1=N2= 35. Considering the likely phenomenon 
of drop-out a N1=N2= 40 is chosen. The sample size is not adjusted for stratification.
Burden and risks
For evaluation of short-term, midterm and long-term effects of the treatment, 
measurements are taken at the beginning of the treatment, after 3 months treatment 
and after 12 (intervention- and control group) and 24 (intervention group only) months 
of follow-up. During these three (four) visits a physical examination is performed, 
cardiovascular fitness measured, a mixed meal test performed and blood samples are 
taken. Children are also asked to complete a quality of life questionnaire.
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D i s C u s s i O n
The increasing prevalence of childhood obesity and its impact on individuals and society 
requires effective preventive programs and therapeutic strategies. The study ‘Haagse 
Maatjes’: an effect evaluation of a family-based cognitive behavioral multidisciplinary 
lifestyle intervention, is a randomized controlled trial with a longitudinal design.  
The study aims to establish long-term weight reduction and stabilization, reduction of 
obesity related health consequences and improvement of the self-image by a change in 
lifestyle. In order to adjust to a healthy lifestyle, thinking patterns, level of physical activity 
and eating behavior of the child with obesity and their family must change. For long term-
effect of the treatment it is also important that coping strategies and social skills are taught 
to children with obesity to deal with low self esteem, low self-control and to teach social 
skills. Also parental involvement and support are necessary for long-lasting, successful 
treatment results.
We hypothesize that after the intensive treatment period the intervention group will show 
a significantly lower BMI-SDS compared to baseline and the control group, and that in 
subjects with a BMI-SDS decrease of more than 0.5, which is considered a clinically relevant 
weight reduction [79,81,93], a significant health improvement (secondary study outcomes) 
is attained. 
The design of the study is prospective with follow-up measurements at 3, 12 and 24 
months. The longitudinal design of the study makes it possible to perform a predictive 
analysis, rather than only cross-sectional correlations. Furthermore, as mentioned by  
the authors of the Cochrane review [77], there is an urgent need for interventions with  
a psychosocial focus for behavioral change and good clinician-family interaction.  
We believe that with our study design we do focus on these important aspects.
The children in the intervention group are followed for 2 years and those in the control 
group for 1 year. Children in the control group are offered the treatment after 1 year,  
since it is preferable to start treatment of obesity as soon as possible. We expect that 
some children will drop out of the study during or after the treatment phase. In our power 
calculation a 10% loss to follow-up was accounted for. 
The strength of our study is that, next to the evaluation of the changes in BMI-SDS after 
intensive lifestyle treatment in obese children, we also assess the effect of weight loss  
on metabolic health status, inflammation, physical fitness, health-related quality of life  
and secretion of some gastrointestinal hormones.
The results of this study will provide more insight in the long-term effects of a family-based 
cognitive behavioral multidisciplinary intervention on weight and BMI-SDS, as well as 
intended health improvement in children with obesity and their family.
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A B B R e V i At i O n s
BMI = Body Mass Index
BMI-SDS = Body Mass Index Standard Deviation Score
CBCL = Child Behavior Checklist
CBSK = Perceived Competence Scale for Children (CompetentieBelevingsSchaal voor Kinderen)
CRP = C-Reactive Protein
GLP-1 = Glucagon-like peptide 1
HDL-cholesterol = High Density Lipoprotein Cholesterol
HOMA-IR = Homeostasis Assessment Model for Insulin Resistance
HRQOL = Health related Quality of Life
MS = Metabolic Syndrome
NVE = Dutch Eating Behavior Questionnaire (Nederlandse Vragenlijst Eetgedrag)
PYY = Peptide YY
QUICKI = quantitative insulin-sensitivity check index
RER = Respiratory Exchange Ratio
TG = Triglyceride
TRF = Teacher Report Form
VO2peak-SDS= Peak oxygen uptake, adjusted for gender and age
VO2peakSDS-kg= Peak oxygen uptake, adjusted for gender age and body weight
WC = Waist Circumference
WC/Ht = Waist to Height Ratio
YSR = Youth Self Report
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A B s t R AC t
Background 
Behavioral lifestyle intervention, combined with parental involvement, is preferred over 
standard care or self-help in childhood obesity. The short-term results of such interventions 
are promising, but long-term follow-up results are equivocal.
Objective 
The objective of the present study was the short (3 months) and long-term (1 and 2 years 
follow up) effect evaluation of a family-based multidisciplinary cognitive behavioral 
lifestyle intervention on markers of adiposity, metabolism, inflammation and physical 
fitness compared to standard care in children with obesity. Also the association between 
these outcome variables was determined.
Methods 
In this prospective longitudinal clinical trial, obese children were randomly assigned  
to a 3 months family-based cognitive behavioral multidisciplinary lifestyle treatment 
(n=40; BMI-SDS 4.2±0.7; age;13.3±2.0yr) or to a control group receiving an initial advice  
on physical activity and nutrition (n=39; BMI-SDS 4.3±0.6; age 13.1±1.9yr). Anthropometric 
data, physical fitness, metabolic parameters and inflammatory state were evaluated  
at baseline, after intervention (at 3 months) and at 1 year follow-up. At 2-year follow-up 
anthropometric data and physical fitness were measured in the intervention group. 
Results
An intervention effect after 1 year was found for adiposity (p=0.02 for BMI-SDS, p=0.03 for 
WC-SDS), physical fitness (VO2peak-SDS, p<0.01) and insulin resistance 
(HOMA-SDS, p=0.04). No significant intervention effect was found for serum lipid profile, 
high-sensitive CRP or adiponectin. At 2 years follow-up BMI-SDS in the intervention group 
(n=31) was 3.8 ± 1.2 SDS, significantly less than at baseline (p=0.02). 
Conclusion 
A positive 1 year follow-up treatment effect was found for adiposity, physical fitness and 
glucose homeostasis, but not for inflammatory markers. There was a significant long-term 
treatment effect on adiposity, although almost all children remained obese. 
trial Registration 
http://www.controlled-trials.com/ISRCTN36146436.
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i n t R O D u C t i O n
The rapidly increasing prevalence of childhood obesity observed during the last few 
decades is assumed to be mostly the result of changes in environmental factors such 
as urbanization, economic growth, technical changes and culture. These changes have 
resulted in a large shift both in diet and physical activity patterns. The modern  
‘Western diet’ is high in saturated fats, sugar, and refined foods, but low in fiber. 
Simultaneously a physically active lifestyle has changed to a more sedentary one (1). 
Obesity in childhood tends to persist into adulthood (2-4), and adult obesity is associated 
with a higher risk for developing type 2 diabetes mellitus and cardiovascular disease (2;4). 
Moreover, it has become clear that the adipose tissue is not just a fat depot, but also an 
endocrine organ, producing hormones and inflammation related factors, that contribute  
to the chronic state of inflammation observed in obesity (5;6). Increased levels of  
the pro-inflammatory cytokines such as high-sensitive C-reactive protein (hsCRP) (7-9) 
and decreased levels of adiponectin have been found in children with obesity and insulin 
resistance (10;11).
An appropriate approach to reduce the obesity related health risks is weight loss.  
Current treatment recommendations for childhood obesity are lifestyle interventions, 
including nutritional and physical activity modification guided by social cognitive 
behavioral techniques (12-14). One of the central assumptions of a cognitive behavioral 
approach is that higher levels of self-confidence increase the likelihood of lifestyle change 
(15). In addition, the lifestyle treatment approach has been shown to be equally successful 
in both clinical, community and school-based settings (13;14;16). Moreover, the results 
of a recent meta-analysis on lifestyle interventions for obese youth showed that lifestyle 
interventions lasting for only a few months can be expected to produce significant 
changes in body weight (13). Also parent involvement in the treatment of obese children 
showed a clearly beneficial effect on treatment results (13;14). A better treatment result is 
found when parents are educated about healthy nutrition and when training in behavioral 
modification was provided (13). Better treatment outcomes have also been observed 
after group therapy compared to individual treatment only, probably the positive effect 
of peer support (17). Furthermore, the intensity of the program, defined as more contact 
time with professional support during the intervention rather than the total duration of 
the intervention, appears important for its efficacy (18). The results of behavioral lifestyle 
interventions on adiposity, metabolism, inflammation and physical fitness immediately 
after treatment are promising (8-10;16;19-23). However, the long-term follow-up effects  
of such interventions on obesity and associated comorbidity are uncertain (18;24).  
A younger age at start and a substantial decrease of BMI-SDS during the intervention  
have been reported to predict a long-term favorable effect (25), but more research  
is needed to delineate the long-term effects of behavioral lifestyle interventions. 
In this paper we report on the short (3 months) and long-term (1 and 2 years) effect of  
a family-based multidisciplinary lifestyle intervention on markers of adiposity,  
physical fitness, metabolic parameters and inflammation compared to standard care  
in obese children. 
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M e t H O D s
study Design and setting
We performed a longitudinal prospective randomized clinical trial to evaluate the effects of 
a family-based multidisciplinary lifestyle intervention on various clinical and physiological 
features of obese children (as defined by Cole et al.(26)) aged 8-17 years, who were referred 
to a pediatric clinic (Juliana Children’s Hospital, the Hague). Children who met the inclusion 
criteria were randomized to receive either a family-based multidisciplinary lifestyle 
intervention or standard care. Before randomization, stratification took place for age 
(8-<12 years and 12-<17 years), gender (male vs. female) and ethnicity (North European 
vs. Others). Normative data for physical fitness, the inflammation parameters and glucose 
homeostasis were collected from a group of healthy children with a normal body weight 
recruited by the youth health services (Jeugd GGD Haaglanden). The study was conducted 
according to the ‘Declaration of Helsinki’ and approval was obtained from the regional 
medical ethical committee Zuid-West Holland. All parents and children gave their written 
informed consent, after they had been given detailed written explanation concerning the 
aim of the study, discomfort and inconvenience and the option to withdraw at any time.
Participants
Potential participants were excluded if their knowledge of the Dutch language, intelligence 
or social skills were insufficient to participate in the trial. Other exclusion criteria were use 
of medication that might have an effect on weight loss, medical co-morbidity that could 
affect participation or previous enrollment in another cognitive behavioral treatment 
program with the focus on reducing obesity. Inclusion criteria were simple obesity,  
8-17 years and referral to a pediatrician. From the 108 obese children who met the 
inclusion criteria, 81 agreed to participate. Most given reasons of refusal were:  
1) not wanting to take the risk to be randomized to the control group and consequently 
wait a year before starting treatment; and 2) not wanting to invest the requested time for 
treatment. Forty-one children were randomized to the intervention group and 40 to  
the control group (Figure 1). The normal weight control group consisted of 34 healthy,  
age, gender and ethnicity matched children with normal body weight for height.
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family-based multidisciplinary lifestyle intervention
The family-based multidisciplinary lifestyle intervention of the intervention group 
consisted of a screening phase of individual counseling of the children with their parents, 
followed by an intensive phase of group sessions during three months. The group 
treatment consisted of 7 group meetings for the children, 5 separate parent meetings  
and 1 parent meeting together with the children. Meetings of 2.5 hours were held once 
every 2 weeks. The children meetings were held on weekday afternoons at the hospital. 
The 5 separate parent meetings were provided on weekdays after working hours. 
Subsequently, refresh follow-up sessions (2-3 sessions/year) were offered for a total period 
of two years (Table 1). 
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figure 1: Flow diagram of participants through the study for the primary outcome 
measure (BMI-SDS)
108 Assessed for eligibility and invited to participate
Refused consent (n=27)
81 Underwent randomization
1 Refused measures at T1 1 Refused measures at T1
2 Discontinued intervention 3 Withdraw for measures at T2
2 refused measures at T2 3 No measures at T2
41 Assigned to Intervention group 40 Assigned to Control group
32 Were included for analysis at T3 35 Were included for analysis at T3
4 lost to follow-up 1 Withdraw
36 Were included for analysis at T2 33 Were included for analysis at T2
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table 1: Characteristics of the Family-based multidisciplinary lifestyle intervention
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During the screening phase, children and their parents were interviewed at two separate 
occasions and all individually by the multidisciplinary team consisting of a dietitian,  
a child-physiotherapist, a child-psychologist and a social worker. Throughout those  
two separate meetings, an individual advice was given by the multidisciplinary team,  
based on the personal situation of each participating family.
Individual 
nutritional advice
A 3-day dietary recall (1 weekend day included) was used by the dietitian to get more 
insight in dietary habits of the children. Information was provided about nutrition and 
healthy eating behavior according to the traffic light nutritional list (40). The traffic light 
nutritional list identifies several main food groups (fruits, vegetables, grains, milk and 
other dairy products, meat, fish, and others). Foods within each group were color-coded 
so as to reflect the caloric density per average serving and Dutch standards for healthy 
nutrition. The colors are green for “go”, orange for “approach with caution”, and red for “stop”. 
The children and parents were involved in planning their own daily diet for themselves 
according to the traffic light nutritional list.
Individual physical 
activity counseling
To obtain insight in the child’s general physical activity behavior during the week, a physical 
activity questionnaire was filled out by a child physiotherapist. Children were asked how 
they traveled to school (by foot, by bicycle, by public transportation or by car), physical 
fitness classes at school, spire time sport activities and daily computer and TV use as well as 
the duration spend at all these activities. The information from this questionnaire was used 
for advice on how to increase and optimize physical activity during everyday life, such as 




By means of motivational interviewing the child psychologist helped the children to 
adapting to a new lifestyle in order to reduce body weight. Before the child started with  
the group sessions individual treatment goals (reduction of 10% of body weight during  
3 months group sessions) were written down in a contract to avoid disappointment.
Children’s group 
meetings
Most children with obesity have negative experiences with group activities. For example, 
they are often not included in social events or chosen last by peer during sport activities. 
Therefore, during the first session much time is spent in getting acquainted with each other. 
A good group bond is important for the effect of the treatment because peer support 
can be very helpful in the treatment of obese children. The main educational focus of 
the first two meetings is on nutritional information of a healthy eating pattern and the 
balance between energy intake and energy expenditure. During the subsequent meetings, 
emphasis was put in self-control techniques to cope with difficult situations (e.g. birthday 
parties, holidays, lunch breaks at school, being at home alone). Problem solving alternatives 
are debated (e.g. to avoid a situation, doing something else, participate in a situation and 
eat less, or participate followed by extra exercise afterwards). Other psycho-educational 
topics reviewed were self-reward (when coping well with a difficult situation) and self-
regulation situations (making a plan how to integrate healthy behavior in daily living).  
Stimulus control was also one of the psycho-educational topics (remove unhealthy stimuli 
at home, encourage healthy behavior, eat at the dinner table, reduction of environmental 
stimuli linked to eating). Topics of the last two meetings were self-image (focus on positive 
things about themselves) and coping strategies on dealing with teasing.
Parent group 
meetings
Topics discussed during the parent meetings included the necessity to change their 
own lifestyle as well, information on healthy nutrition (product information, quantities, 
eating moments, eating locations) and how to help their children. Parents received 
advice on parenting styles (boundaries setting with regard to eating behavior, giving 
positive feedback). During the last meeting a therapist discusses the role of all other 
family members with regard to the treatment in the family (e.g. are other family members 
supportive, how do they cope with the lifestyle changes).
Follow-up meetings In order to maintain the newly learned behavior refresh follow-up meetings were given 
during the first two years (2-3 meetings/ year). The child psychologist and the social worker 
organize this follow-up meetings. The topics repeated were: problem solving techniques 
and relapse prevention techniques.
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The control group received standard care and advice, at start of the trial, on how to 
increase their physical activity, decrease their sedentary activities and improve their eating 
behavior according to Dutch standards for healthy nutrition. After 1 year all children 
in the control group were offered the opportunity to participate in the family-based 
multidisciplinary lifestyle intervention. 
Clinical Measures
Measurements were taken before (T1) and after the 3 months treatment in the intervention 
group (T2) and after a follow-up period of 12 months after start (T3). The intervention 
group was also evaluated after 24 months (T4). In the normal weight control group tests 
and blood samples were determined once.
Weight was measured to the nearest of 0.1 kg using an electronic scale (SECA 911,  
Vogel & Halke, Hamburg, Germany) and height to the nearest of 0.1 cm with a stadiometer 
(Holtain, limited, Crymych, Dyfed, Britain) in underwear and barefoot by an experienced 
assistant. The BMI was calculated as weight / height squared (kg/m2). Subjects were 
classified as obese using BMI gender- and age specific international cut-off levels (26). 
BMI was expressed as standard deviation score (SDS) for Dutch references (27). The 1980 
reference data for weight and height were used to obtain a realistic view on the degree of 
obesity without data being biased by the increased prevalence rate of childhood obesity. 
Waist circumference (WC, in cm) was measured with an anthropometric tape midway 
between the lower rib margin and the iliac crest at the end of gentle expiration and 
expressed as SDS (WC-SDS) (28). The WC/height (both in cm) ratio (WC/Ht) was used as  
an additional measure for increased health risk. Blood pressure was determined in  
a relaxed sitting position measurement with an electronic device (Criton Dinamap,  
No. 8100), in duplicate; the last measurement was used for further analysis.
Ethnicity was determined according to self-reports by the parents. For this analysis subjects 
were classified as ‘Northern European’ (38% of the total sample) when both parents 
reported the Northern European ethnicity, and ‘Others’ (62%) when one or both parents 
reported another ethnicity. Subjects in the ‘Others’ group were mainly of Hindustani  
(28% of total sample) and Mediterranean (28% of total sample) origin. 
Pubertal development was recorded by the pediatrician according to Tanner (29).  
Breast development in girls and genital development in boys was used for pubertal 
classification into two groups: prepubertal (breast or genital stage ≤1) and pubertal  
(stages 2-5).
Voluntarily Maximal exercise test
The physical fitness of the children was determined by a voluntary maximum exercise test 
on a treadmill using breath-by-breath analysis and plots according to Wasserman (30).
The exercise test consisted of three stages; a reference stage (2 minutes rest prior to  
the exercise test), the test stage (the exercise test until voluntary exhaustion occurred)  
and a recovery stage (2 minutes recovery measurement in rest after the exercise test). 
The test stage started with a velocity of 4 km/h and an angle of 0% during 1 minute. 
Every minute the velocity increased with 0.5 km/h and the angle with 2%, until voluntary 
exhaustion occurred. During the test all subjects were verbally encouraged to perform 
maximally. At the end of the test the children were asked to grade the level of exhaustion 
using the Borg scale (31) and explain their reason to end the test.
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Peak values were based on heart rate and a Respiratory Exchange Ratio (RER) of > 1.0 
between oxygen uptake (VO2) and carbohydrate output (VCO2). This level is in children 
equivalent with the anaerobic threshold at which point exhaustion starts (32). This latter 
criterion is a generally accepted approach to establish if peak values are reached.  
The physical fitness was determined from the absolute measured peak value of oxygen 
uptake (ml/min), standardized for age and gender (VO2peak-SDS). Also the peak oxygen 
uptake adjusted for body weight was determined by dividing the absolute oxygen uptake 
by body weight (ml/min/kg) and standardized it for age and gender (VO2peak-SDS-kg). 
In obese subjects it is common to use this latter approach for physical fitness because  
the peak value of the absolute oxygen uptake is biased since obese subjects usually also 
have a large absolute amount of muscle weight compared to normal weight peers (30). 
Biochemical Measures
With the subject in a supine position, blood samples were taken by venipuncture after  
an overnight fast. Before blood sampling, the fasting state was verbally confirmed by  
the participant and the parent(s). After sampling blood, serum samples of insulin, 
adiponectin and hsCRP were stored at -80ºC before analysis. All blood samples were 
analyzed in accredited clinical chemical and hematology laboratories (HagaHospital,  
the Hague and Leiden University Medical Center, Leiden, The Netherlands) 
Glucose was analyzed from lithium heparine plasma by the glucose-oxydase method 
with the Unicel DxC 800 (Beckman Coulter, Woerden, the Netherlands). Plasma insulin 
was analyzed by a RIA method (DSL-1600, Beckman Coulter, Woerden, the Netherlands; 
intra-assay coefficient of variation 4.5-8.3%; inter-assay coefficient of variation 4.7-12.2%; 
sensitivity 1.3μU/ml). An index for insulin resistance was calculated according to  
the Homeostasis Model Assessment for insulin resistance (HOMA-IR) formula:  
(fasting insulin (μU/mL) x fasting glucose (mmol/L)) / 22.5 (33). Standard deviation scores 
for HOMA-IR (HOMA-SDS) were calculated, based on gender- and age- specific reference 
values (34). 
HDL cholesterol was analyzed by homogenic enzymatic colorimetry and triglyceride 
(TG) by automatized colorimetry, both determined by bynchon Lx20 Pro/ unicel DXC 800 
(Beckman Couter, Brea, US).
High-sensitive CRP was analyzed by immune-turbidimetric assay with Cobas Integra 800 
(Roche Diagnostics, Indianapolis, IN, USA; measuring range 0.15-20.0 mg/L; sensitivity  
0.3 mg/L with an inter-assay coefficient of variation <10%). Adiponectin was assayed  
by human adiponectin RIA (adiponectin kit hadp-61hk, Millipore, Billerica, MA, USA;  
intra-assay coefficient of variation 1.78-6.21%; inter-assay coefficient of variation 6.9-9.25%; 
sensitivity; 0.78 ng/mL). 
statistical Analysis
The analysis was performed using the Statistical Package for Social Science version 17.0 
for Windows (SPSS Inc., Chicago, IL, USA) and the level of significance was set at p<0.05. 
Data were checked for normality before analysis, using descriptive statistics for skewness, 
kurtosis and Shapiro-Wilk test. Fasting insulin was transformed to the natural logarithm. 
Data were expressed as mean ± standard deviation (continuous variables) and as count 
and percentage (categorical variables) unless defined otherwise. One-way ANOVA, with 
Bonferroni correction for multiple testing, was used to compare the intervention group, 
obese control group, and normal weight control group at baseline. ANOVA for repeated 
measures were used to determine the mean study parameters over time per group 
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(intervention and obese control group). The mixed model for repeated measures was used 
to determine the effect of intervention (mean difference between change in intervention 
and control group) over time for all the parameters separately, adjusted for baseline 
values. Pearson correlation analysis was used to assess the associations between the study 
parameters at baseline. 
R e s u Lt s
Clinical baseline data of 79 obese children (n=40 in the intervention group and n=39 
controls) and of 34 normal weight children are shown in table 2. The ratio prepubertal 
(Tanner ≤ 1) vs. pubertal (Tanner 2-5) children was not significantly different between 
groups (p=0.11). At baseline the intervention and obese control group did not 
significantly differ in measures of adiposity (BMI-SDS, WC-SDS, WC/Ht), physical fitness 
(VO2peak-SDS, VO2peak-SDS-kg), metabolic parameters (insulin, glucose, HOMA-SDS, HDL, 
TG, blood pressure) and inflammation (adiponectin, hsCRP). At baseline the parents of 
both intervention and obese control group were on average obese as well, showing no 
significant difference between groups; BMI of the father (30.0 ± 7.1 kg/m2 vs. 28.4 ± 4.4 kg/
m2, respectively) and BMI of the mother (31.0 ± 9.0 kg/m2 vs. 31.2 ± 6.2 kg/m2).
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intervention group 
(n=40)
Control group  
(n=39)
normal weight  
Control group (n=34)
Gender (M/F) 18/22 19/20 14/20
Ethnicity (North European/Other) 14/26 11/28 18/16
Puberty (Tanner ≤1/ 2-5) 5/35 8/31 7/27
Age (yr.) 13.3 ± 2.0 13.1 ± 1.9 13.2 ± 2.4
Weight (kg) 85.7 ± 18.4* 85.7 ± 18.6* 51.7 ± 15.1
Height (cm) 161.9 ± 9.7 161.4 ± 11.0 160.2 ± 14.1
BMI (kg/m2) 32.4 ± 4.7* 32.5 ± 3.9* 19.7 ± 3.3
BMI-SDS 4.2 ± 0.7* 4.3 ± 0.6* 0.5 ± 1.4
 WC (cm) 91.1 ± 9.1* 90.5 ± 7.7* 67.0 ± 8.7
WC-SDS 3.7 ± 1.0* 3.7 ± 0.9* 0.3 ± 0.9
WC/Ht 0.56 ± 0.04* 0.56 ± 0.04* 0.42 ± 0.04
VO2peak-SDS 1.7 ± 1.5* 2.2 ± 1.5* 0.0 ± 1.4
VO2peak-SDS-kg -3.0 ± 1.0* -2.8 ± 1.0* -0.8 ± 1.1
Glucose (mmol/L) 5.3 ± 0.4 5.2 ± 0.4 5.2 ± 0.5
Insulin (mU/L) 19.5 ± 12.2* 14.9 ± 8.0 13.5 ± 9.1
HOMA-IR 4.6 ± 2.9 3.4 ± 1.9 3.2 ± 2.3
HOMA-SDS 2.1 ± 2.3* 1.2 ± 1.3 1.0 ± 2.1
HDL (mmol/L) 1.1 ± 0.3* 1.1 ± 0.2* 1.3 ± 0.2
Triglycerides (mmol/L) 1.2 ± 1.0* 0.9 ± 0.5 0.7 ± 0.3
Systolic Blood Pressure (mmHg) 125 ± 13* 126 ± 12* 119 ± 9
Diastolic Blood Pressure (mmHg) 65 ± 9 65 ± 7 67 ± 9
Adiponectin (ng/mL) 8.6 ± 3.8 8.5 ± 3.3 9.7 ± 4.0
hsCRP (mg/L) 2.3 ± 2.1 1.8 ± 1.5 0.6 ± 0.9
Results are expressed as mean ± sd.
*significantly different compared to normal weight control group, p <0.05, tested using ANOVA for comparing  
between groups
table 2: Baseline subject characteristics
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Obese subjects in both intervention and control groups showed a significantly (p<0.01) 
lower physical fitness (VO2peak-SDS, VO2peak-SDS-kg) and HDL compared to the normal 
weight control group and a higher systolic blood pressure (SBP) (p=0.02 and p=0.06, 
respectively). Significantly higher fasting insulin (p=0.03), HOMA-SDS (p=0.05) and TG 
(p=0.01) were found in the obese intervention group compared to the normal weight 
control group. 
During the 3 months intensive phase of the treatment 5 boys and 5 girls missed  
2 meetings, 2 boys and 5 girls missed one meeting, the remaining children attended  
all group meetings. The short-term (T2 at 3 months) and long-term (T3 after 1 yr follow-up)  
results are shown in table 3. On both these study occasions measures of adiposity were 
significantly reduced in the intervention group, with 10% decreased BMI-SDS and 19% 
decreased WC-SDS after 1 year follow-up compared to baseline. The corresponding 
values in the obese control group remained unchanged compared to baseline. After 1 
year follow-up the VO2peak-SDS-kg in the intervention group had increased by 20%, while 
a reduction of 18% was observed in the obese control group (Figure 2). Borg scores for 
subjective experienced exhaustion did not significantly change over time within and 
between groups. Measures for fasting insulin and HOMA-SDS were equal to baseline values 
in the intervention group at all study occasions. In the control group these measure slightly 
increased compared to baseline. Blood pressure decreased more in the intervention group 
versus baseline values compared to the obese control group. Lipid profile  
and inflammatory state in both groups remained unchanged.
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intervention group Control group
t1 (n=40) t2 (n=36) t3 (n=32) t1 (n=39) t2 (n=33) t3 (n=35)
BMI-SDS 4.2 [4.0;4.4] 4.0 [3.7;4.3] 3.8 [3.4;4.2] 4.3 [4.1;4.5] 4.2 [4.0;4.5] 4.2 [4.0;4.5]
WC-SDS 3.7 [3.3;4.0] 3.4 [2.9;3.8] 3.0 [2.5;3.6] 3.7 [3.4;4.0] 3.7 [3.3;4.1] 3.5 [3.1;4.0]
WC/Ht 0.56 [0.55;0.58] 0.55 [0.53;0.57] 0.53 [0.51;0.56] 0.56 [0.55;0.57] 0.56 [0.55;0.58] 0.56 [0.54;0.57]
VO2peak-SDS 1.7 [1.2;2.2] 1.7 [1.2;2.2] 1.7 [1.1;2.3] 2.2 [1.7;2.7] 1.7 [1.2;2.2] 1.1 [0.6;1.6]
VO2peak-SDS-kg -3.0 [-3.3;-2.6] -2.7 [-3.1;-2.3] -2.4 [-3.0;-1.9] -2.8 [-3.2;-2.5] -2.9 [-3.3;-2.5] -3.3 [-3.7;-2.9]
Glucose 
(mmol/L)
5.3 [5.1;5.4] 5.3 [5.1;5.4] 5.1 [5.0;5.2] 5.2 [5.1;5.3] 5.3 [5.0;5.6] 5.1 [5.0;5.3]
Insulin (mU/L) 19.5 [15.6;23.4] 17.4 [13.1;21.7] 20.5 [15.2;25.9] 14.9 [12.3;17.5] 20.3 [15.5;25.0] 18.8 [15.6;21.9]
HOMA-SDS 2.1 [1.4;2.9] 1.7 [0.8;2.5] 2.2 [1.1;3.3] 1.2 [0.7;1.6] 2.2 [1.1;3.4] 1.7 [1.2;2.3]
HDL (mmol/L) 1.1 [1.1;1.2] 1.1 [1.0;1.2] 1.1 [1.0;1.2] 1.1 [1.1;1.2 1.2 [1.0;1.3] 1.1 [1.0;1.2]
TG (mmol/L) 1.2 [0.8;1.5] 1.2 [0.9;1.5] 1.1 [0.8;1.4] 0.9 [0.8;1.1] 1.0 [0.9;1.2] 1.0 [0.8;1.3]
SBP (mmHg) 125 [121;129] 123 [119;127] 118 [114;122] 126 [123;131] 125 [121;129] 122 [177;128]
DBP (mmHg) 65 [62;67] 59 [56;62] 57 [54;61] 65 [62;67] 62 [ 58;66] 59 [56;62]
Adiponectin 
(ng/mL)
8.6 [7.4;9.8] 9.2 [7.5;10.9] 9.4 [7.4;11.4] 8.5 [7.4;9.6] 9.1 [7.8;10.5] 8.9 [7.3;10.5]
hsCRP (mg/L) 2.3 [1.6;3.0] 1.9 [1.2;2.6] 1.9 [1.1;2.8] 1.8 [1.3;2.3] 2.5 [1.4;3.7] 2.1 [1.5;2.8]
Results are expressed as mean [95% CI].
table 3: Outcome parameters at start (T1), after 3 months (T2) and after 12 months (T3) 
in the intervention and control groups
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The effect of the intervention on the outcome parameters after 1 year follow-up is shown 
in table 4 as well. In order to adjust for differences in baseline values between groups,  
the baseline values were put in the model as covariates. The mean differences between  
the intervention and obese control group, adjusted for baseline differences, were 
statistically significant for all the parameters of adiposity (BMI-SDS, WC-SDS, WC/Ht), 
physical fitness (VO2peak-SDS, VO2peak-SDS-kg) and for HOMA-SDS.
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figure 2: Physical fitness over time in Intervention and Control group
Parameters intervention group Obese control group Difference between  
two obese groups
Change during 
first 12 months 
95% Ci Change during 
first 12 months




BMI-SDS -0.4 -0.8; 0.0 -0.1 -0.4; 0.3 -0.2 [0.03;0.42] 0.02
WC-SDS -0.6 -1.2; -0.0 -0.2 -0.7; 0.5 -0.4 [0.04;0.78] 0.03
WC/Ht -0.03 -0.06; 0.0 -0.01 -0.03; 0.0 -0.02 [0.001;0.034] 0.03
VO2peak-SDS 0.0 -0.7; 0.8 -1.1 -1.8;-0.4 0.7 [-1.1;-0.3] <0.01
VO2peak-SDS-kg 0.5 -0.0; 1.1 -0.4 -0.9; 0.1 -0.7 [-1.1;-0.4] <0.01
Glucose (mmol/L) -0.2 -0.3; 0.0 -0.0 [-0.3; 0.2] 0.1 [-0.1;0.3] NS
Insulin (mU/L) 1.0 -7.2; 5.2 3.9 -1.1; 8.9 -4.0 [-0.0;8.0] 0.05
HOMA-SDS 0.1 -1.1; 1.1 0.6 -0.5;1.6 -0.9 [0.0;1.7] 0.04
HDL (mmol/L) -0.0 -0.2; 0.1 -0.0 -0.2;0.1 -0.03 [-0.11;0.06] NS
Triglycerides 
(mmol/L)
-0.1 -0.5; 0.4 0.1 -0.2; 0.4 -0.04 [-0.3;0.2] NS
SBP (mmHg) -6.6 -12.2; -1.0 -4.3 -10.2; 1.7 -2.8 [-7.0;1.5] NS
DBP (mmHg) -7.3 -11.5;-3.1 -5.7 -10.0; -1.3 -3.2 [-6.7;0.4] NS
Adiponectin (ng/
mL)
0.8 -1.5; 3.0 0.4 -1.4; 2.3 0.2 [-0.9;1.4] NS
hsCRP (mg/L) -0.4 -1.4; 0.6 -0.9 -3.2; 1.4 -0.8 [-1.6;0.1] NS
table 4: Effect of intervention on markers of adiposity, physical fitness, metabolic parameters 
and inflammation
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At 2-year follow-up, data on adiposity and physical fitness were available in 31 children  
in the intervention group. Measures for adiposity were similar to T3 (3.8 ± 1.2 BMI-SDS  
and 3.2 ± 1.8 WC-SDS). BMI-SDS was still significantly lower than at baseline in these  
31 children (4.2 ± 0.7 SDS, p=0.02) but only 3 children reached a BMI < +2 SDS. The physical 
fitness adjusted for body weight was still 10% better compared to baseline, but had 
returned to the T2 value (-2.7 ± 1.4mL/min/kg). 
Pearson correlation analyses between the study parameters at baseline are shown in 
table 5. A strongly significant inverse correlation was found between adiposity (BMI-SDS, 
WC-SDS, WC/Ht) and VO2peak-SDS-kg. A less pronounced positive relation was found for all 
markers for adiposity with metabolic parameters (fasting insulin, HOMA-SDS, TG, SBP)  
and hsCRP and an inverse relationship with HDL and adiponectin. Physical fitness, adjusted 
for body weight, correlated inversely with metabolic parameters (fasting insulin, fasting 
glucose, HOMA-SDS, TG, SBP) and with hsCRP, and correlated positively with HDL  
and adiponectin. An inverse correlation was found between adiponectin and HOMA-SDS 
and SBP. A positive correlation was found between adiponectin and HDL. 
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HDL TG SBP DBP Adiponectin hsCRP
BMI-SDS -
WC-SDS .903** -
WC/Ht .899** .962** -
VO2peak-
SDS
.549** .620** .487** -
VO2peak-
SDS-kg
-.707** -.737** -.755** -.061 -
Fasting 
Glucose
.032 .042 .091 -.158 -.186* -
Fasting 
Insulin
.330** .331** .298* .040 -.354** .304** -
HOMA- 
SDS
.189** .217* .239* -.017 -.356** .457** .433** -
HDL -.459** -.466** -.429** -.326** .319** -.048 -.223* -.243** -
TG .258** .282** .249** .139 -.218* .047 .366** .125 -.370** -
SBP .306** .398** .379** .173 -.381* .056 .163 .213* -.286** .202* -
DBP -.010 .054 .058 .012 -.018 -.008 .049 .079 -.097 .114 .269** -
Adiponectin -.260** -.272** -.240* -.118 .250** -.049 -.391** -.297** .323** -.110 -.220* .001 -
hsCRP .221* -.189* .242** .070 -520** .106 -.008 -.036 -.197* -.056 .043 .109 -.089 -
* correlation is significant at the 0.05 level (2-tailed);  
** correlation is significant at the 0.01 level (2-tailed)
table 5: Pearson correlation Coefficients of the study parameters at baseline
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D i s C u s s i O n
Our family-based multidisciplinary lifestyle intervention showed a positive effect on all 
parameters of adiposity and physical fitness directly after the intervention and at follow up 
after 1 and 2 years. We also found a modest but significant intervention effect on insulin 
resistance (expressed as HOMA-SDS), i.e. unchanged values over time in the intervention 
group compared to increasing values of HOMA-SDS with persisting adiposity in the obese  
control group. Results for parameters of lipid profile and inflammation showed  
no significant treatment effect.
The current recommendation for treating childhood obesity is a multidisciplinary lifestyle 
intervention with parental involvement. However, only few programs have been evaluated 
and the effect on retaining weight reduction over time is small to moderate (14;16;35). 
These previous observations are confirmed by our study, showing a positive short- and 
long-term intervention effect on adiposity and physical fitness. Concerning the short-term 
treatment effect on adiposity, our results are similar to those of numerous previous studies 
on multidisciplinary lifestyle interventions in obese children (16;20;21;24). The follow-up 
results of such interventions are more diverse. While, in agreement with our findings,  
some investigators observed still a reduced BMI-SDS after ≥ 1 year follow-up (14;18), others 
reported less favorable follow-up results (14;21). Nevertheless, on average the children were 
still obese during these follow-up measures. However, even if such interventions cannot 
reduce body weight to the normal range, beneficial results on health can be accomplished 
by improving physical fitness, nutritional habits and coping strategies (14;35).
Waist circumference is used as a safe, easy and inexpensive way to measure abdominal 
obesity in adults and children, and is considered a good indicator of increased metabolic 
and cardiovascular risk (36). According to a previous study obese children only had an 
increased metabolic and cardiovascular risk compared to normal weight children if WC  
was >90th percentile for age and gender (36). In addition, among Asian Indian adolescents 
the odds of having hypertension was more pronounced for increased WC (5.21; 95% CI 
[2.14 to 12.17]) than for increased BMI (2.90; 95% CI [1.40 to 6.12]) (37). These findings 
suggest that during treatment not only a reduction of BMI-SDS but also a lower WC  
is important to establish a beneficial health effect. In this light our observations of  
a significant positive treatment effect on WC-SDS over time suggests to be of greater 
importance for improvement of metabolic risk than the reduction of BMI-SDS.
The beneficial effect of multidisciplinary lifestyle interventions has been shown to 
increase when parents are in some way involved in the intervention (35). So, in order to 
achieve a larger treatment effect more emphasis should be put on motivating the parents 
to participate and support their child. The inclusion of the parents in the treatment of 
childhood obesity is challenging and health professionals are often confronted with  
the lack of parental motivation and with time constraints of the parents. A further obstacle 
in the struggle against childhood obesity is the unrealistic treatment expectations of 
children and parents. In most studies, including the current one, children who participate 
in a multidisciplinary lifestyle intervention do not lose all their excess body weight,  
which most families find difficult to accept. In order to match expectations with treatment 
objectives, it is advised to include an interview with the child and parents prior to  
the program. The purpose of this interview is to give the family a chance to reflect their 
willingness to participate, and discuss achievable realistic treatment goals. Although we 
included such an interview in our program, the child and parents kept focusing on the 
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absolute amount of body weight loss and found it difficult to maintain the newly learned 
lifestyle. Therefore, the period immediately after the family-based multidisciplinary lifestyle 
intervention is critical for motivating children and their parents to maintain their changed 
lifestyle. In this respect, it may be important to emphasize the favorable effects of  
the achieved results in terms of body proportions and metabolic parameters, rather than 
the modest weight reduction obtained by the large majority. 
Besides the treatment effect on adiposity, we also found a significant effect on physical 
fitness. Our data showed a significant improvement of fitness over time as opposed to  
a significant deterioration of physical fitness when BMI-SDS was unchanged as seen in  
the untreated controls. It has been suggested that the measured absolute peak oxygen 
uptake in obese subjects may overestimate the real physical fitness because of their 
increased body size (30). For that reason the peak oxygen uptake adjusted for body weight, 
age and gender (VO2peak-SDS-kg) is often determined to establish a more realistic value for 
the physical fitness. In line with earlier studies (20;38), we found in our intervention group 
unchanged absolute physical fitness (VO2peak-SDS) over time, while physical fitness adjusted 
for body weight improved. It appears that absolute fitness is unaffected by treatment,  
but both measures for physical fitness diminished over time in our obese control group.  
A stable absolute physical fitness over time has been suggested to be indicative of training 
adaptation (38). As peak oxygen consumption is directly related to fat free mass (30)  
and subjects’ fat mass as well as their fat-free mass often decrease during weight reduction, 
their absolute physical fitness is expected to be lower at the end of treatment. An obstacle 
in maintaining prolonged weight reduction is, however, that during weight loss  
not only body weight decreases, but as a consequence of the reduced body weight,  
also the average daily energy requirements. For prolonged weight reduction it will be 
beneficial to increase physical fitness in order to prevent loss of fat free mass during  
the weight loss period. Since we did not measure the fat free mass in our study, we were 
unable to determine a possible positive training adaption. 
 
The intervention did not improve insulin resistance, but still a treatment effect was 
observed because of the increased insulin resistance in the control group. In contrast to 
our results, prior studies have found a significantly decreased HOMA-IR and fasting insulin 
after a lifestyle intervention. These decreased markers for insulin resistance were found 
when clinically significant weight reduction (>0.5 BMI-SDS) occurred (22), or when BMI  
and body weight were significantly reduced (19). It should, however, be noted that  
the result of the latter study was found in only 48 of the 104 children (47.5%) after 
completion of the intervention. Therefore, it is conceivable that, in this study, markers  
for insulin resistance were determined only in the children with weight reduction. 
The results of the present study confirm the previously reported association between 
childhood obesity and the presence of a pro-inflammatory state, indicated by a significantly 
increased hsCRP serum concentration (7-9). On the contrary, adiponectin exerts an anti-
atherogenic and has previously been found in lower concentrations in obese compared to 
normal weight children (10;19;22). Adiponectin is also reported to improve insulin sensitivity 
(39). In contrast to these earlier studies, we found similar adiponectin concentrations in the 
obese and lean children. A beneficial effect of our family-based multidisciplinary lifestyle 
intervention on the inflammatory state was absent. In earlier studies, a clinically significant 
BMI-SDS reduction of > 0.5 has been (9;22) associated with a significant increase in 
adiponectin and decrease in hsCRP. We speculate that the modest BMI-SDS reduction  
after intervention may explain the absence of a treatment effect on both.
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One of the limitations of this study is that our study population consisted of a clinically 
referred sample and thereby may be influenced by selection and referral bias, and thus 
may not be representative for all (severely) obese children in the general population. 
Treatment seeking children with obesity probably experience more disadvantages from 
their excess body weight and are therefore perhaps more motivated than their obese 
peers in the community. Another limitation of the current study is that for the follow-up at 
2 years no obese control data were available, since, for ethical reasons, the obese control 
group was offered the same intervention at 1-year follow-up. Finally, it is unknown what 
the predictive value is of two year follow-up data for health and behavior in later years. 
The strength of this study is the prospective, randomized and controlled study design, with 
sufficient statistical power, and the breadth of outcome parameters, including physical 
fitness. Since at all points in time during our study measurements were taken by the same 
person under similar conditions, the results cannot be biased by inter-observer errors. 
In conclusion, our intensive family-based multidisciplinary lifestyle intervention resulted  
in a modest long-term reduction of both total and abdominal adiposity accompanied by  
improved physical fitness, while unchanged adiposity in untreated controls led to 
decreased physical fitness and deterioration of insulin resistance state. No effect was seen 
on inflammatory markers, probably because almost all children remained obese. 
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Objective
This study aims to evaluate the effect of multidisciplinary treatment of obesity on plasma 
concentrations of several gut hormones in fasting condition and in response to a mixed 
meal in children.
Methods
Complete data were available from 36 obese children (age 13.3±2.0yr). At baseline  
and after the 3-months multidisciplinary treatment, fasting and postprandial blood 
samples were taken for glucose, insulin, ghrelin, peptide YY (PYY) and glucagon  
like peptide 1 (GLP-1). 
Results
BMI-SDS was significantly reduced by multidisciplinary treatment (from 4.2±0.7 to  
4.0±0.9, p<0.01). The intervention significantly increased the area under the curve (AUC) 
of ghrelin (from 92.3±18.3 to 97.9±18.2 pg/L, p<0.01), but no significant changes were 
found for PYY or GLP-1 concentrations (in fasting or postprandial condition). The insulin 
resistance index (HOMA-IR) remained unchanged as well.
Conclusion
Intensive multidisciplinary treatment induced moderate weight loss and increased  
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i n t R O D u C t i O n
Childhood obesity has become a global problem (1). Understanding the mechanisms  
that control energy balance and fuel flux in children is of paramount importance for  
the design of effective strategies to combat this health hazard. The gastrointestinal tract 
plays a critical role in the control of feeding behavior and fuel metabolism. In response 
to food intake, the gut produces a variety of hormones that inhibit food intake, promote 
glucose induced insulin release and/or facilitate insulin action (e.g. glucagon-like peptide 1 
(GLP-1), peptide YY (PYY)) (2-4). Conversely, in the absence of food, the stomach produces 
ghrelin, which stimulates appetite to initiate feeding (4;5). 
In a number of studies plasma levels of ghrelin in obese children were compared with 
those of normal weight controls. Generally, the plasma ghrelin concentration of obese 
children is lower in fasting condition (6-10), whereas the decline in response to glucose 
ingestion varies as a function of insulin sensitivity; the decline appears to be less profound 
in insulin resistant obese children (6;11), although the data are equivocal (12).  
Weight loss tends to normalize circulating ghrelin levels (8;10;13), although this is still 
subject for debate (5;14). 
In fasting condition, plasma GLP-1 and PYY levels were reported to be similar in obese  
and lean children (9;15-18), but in other studies lower PYY (19) and lower GLP-1 were found 
in obese children (20). Postprandial concentrations of the two hormones are consistently 
lower in obese vs. normal weight peers (15;20;21). The few studies that have examined  
the effect of weight loss on the release of these hormones in obese children found 
significantly increased fasting PYY (19) and (surprisingly) decreased fasting GLP-1 (18)  
after weight reduction. 
Because gut hormones are intimately involved in the control of energy balance, better 
understanding of intestinal endocrine (mal)function in obese children may contribute to 
the development of strategies to treat their condition. Here we aim to evaluate the effect 
of a 3 months’ multidisciplinary intervention program to reduce the bodyweight of obese 
children on plasma gut hormone concentrations in fasting condition and in response to  
a standard meal.
The Effect of Multidisciplinary Lifestyle Intervention on the Pre- 
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M At e R i A L s  A n D  M e t H O D s
Participants, study design and settings
This study is part of a randomized clinical trial on the effect of multidisciplinary treatment 
on childhood obesity (22). Here the effects of lifestyle intervention on various clinical  
and physiological features of the obese children in the intervention group are analyzed. 
The study inclusion criteria were simple obesity (as defined by Cole (23)), age 8-17 years 
and referral to a pediatrician. Potential participants were excluded if their knowledge of 
the Dutch language, intelligence or social skills were insufficient to participate in the trial. 
Other exclusion criteria were use of medication that might have an effect on weight loss, 
medical co-morbidity (e.g. hypothyroidism, high dose of glucocorticoids, diabetes mellitus) 
that could affect trial outcome or previous enrollment in another cognitive behavioral 
treatment program with a focus on reducing body weight. Forty-one children were 
randomized to the intervention group, of whom 36 completed the treatment. The study 
was conducted according to the ‘Declaration of Helsinki’, and approval was obtained from 
the regional medical ethical committee South West Holland. All parents and children gave 
their written informed consent after they had been given detailed written explanations  
of the aims of the study, discomfort, and inconvenience, and the option to withdraw  
at any time.
intervention
The multidisciplinary lifestyle treatment of the intervention group consisted of a screening 
phase of individual counseling of the children with their parents, followed by an intensive 
phase of group sessions during three months. The group treatment consisted of 7 group 
meetings for the children, 5 separate parent meetings and 1 parent meeting together with 
the children. Meetings of 2.5 hours were held once every 2 weeks. The children meetings 
were held on weekday afternoons at the hospital. The 5 separate parent meetings were 
provided on weekdays after working hours. Subsequently, refresh follow-up sessions  
(2-3 sessions/year) were offered for a total period of two years (Table 1).
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During the screening phase, children and their parents were interviewed at two separate 
occasions and all individually by the multidisciplinary team consisting of a dietitian,  
a child-physiotherapist, a child-psychologist and a social worker. Throughout those  
two separate meetings, an individual advice was given by the multidisciplinary team,  
based on the personal situation of each participating family. 
Individual 
nutritional advice
A 3-day dietary recall (1 weekend day included) was used by the dietitian to get more 
insight in dietary habits of the children. Information was provided about nutrition  
and healthy eating behavior according to the traffic light nutritional list (28). The traffic 
light nutritional list identifies several main food groups (fruits, vegetables, grains, milk and 
other dairy products, meat, fish, and others). Foods within each group were color-coded 
so as to reflect the caloric density per average serving and Dutch standards for healthy 
nutrition. The colors are green for “go”, orange for “approach with caution”, and red for “stop”. 
The children and parents were involved in planning their own daily diet for themselves 
according to the traffic light nutritional list.
Individual physical 
activity counseling
To obtain insight in the child’s general physical activity behavior during the week, a physical 
activity questionnaire was filled out by a child physiotherapist. Children were asked how 
they traveled to school (by foot, by bicycle, by public transportation or by car), physical 
fitness classes at school, spire time sport activities and daily computer and TV use as well as 
the duration spend at all these activities. The information from this questionnaire was used 
for advice on how to increase and optimize physical activity during everyday life, such as 




By means of motivational interviewing the child psychologist helped the children to 
adapting to a new lifestyle in order to reduce body weight. Before the child started with  
the group sessions individual treatment goals (reduction of 10% of body weight during  
3 months group sessions) were written down in a contract to avoid disappointment.
Children’s group 
meetings
Most children with obesity have negative experiences with group activities. For example, 
they are often not included in social events or chosen last by peer during sport activities. 
Therefore, during the first session much time is spent in getting acquainted with each other. 
A good group bond is important for the effect of the treatment because peer support 
can be very helpful in the treatment of obese children. The main educational focus of 
the first two meetings is on nutritional information of a healthy eating pattern and the 
balance between energy intake and energy expenditure. During the subsequent meetings, 
emphasis was put in self-control techniques to cope with difficult situations (e.g. birthday 
parties, holidays, lunch breaks at school, being at home alone). Problem solving alternatives 
are debated (e.g. to avoid a situation, doing something else, participate in a situation and 
eat less, or participate followed by extra exercise afterwards). Other psycho-educational 
topics reviewed were self-reward (when coping well with a difficult situation) and self-
regulation situations (making a plan how to integrate healthy behavior in daily living). 
Stimulus control was also one of the psycho-educational topics (remove unhealthy stimuli 
at home, encourage healthy behavior, eat at the dinner table, reduction of environmental 
stimuli linked to eating). Topics of the last two meetings were self-image (focus on positive 
things about themselves) and coping strategies on dealing with teasing. 
Parent group 
meetings
Topics discussed during the parent meetings included the necessity to change their 
own lifestyle as well, information on healthy nutrition (product information, quantities, 
eating moments, eating locations) and how to help their children. Parents received 
advice on parenting styles (boundaries setting with regard to eating behavior, giving 
positive feedback). During the last meeting a therapist discusses the role of all other 
family members with regard to the treatment in the family (e.g. are other family members 
supportive, how do they cope with the lifestyle changes). 
Follow-up meetings In order to maintain the newly learned behavior refresh follow-up meetings were given 
during the first two years (2-3 meetings/ year). The child psychologist and the social worker 
organize this follow-up meetings. The topics repeated were: problem solving techniques 
and relapse prevention techniques. 
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Clinical Measures
In this paper the measurements taken at baseline (T1) and after 3 months treatment (T2)  
are analyzed and discussed. Weight was measured to the nearest of 0.1 kg using  
an electronic scale (SECA 911, Vogel & Halke, Hamburg, Germany) and height to the nearest 
of 0.1 cm with a stadiometer (Holtain, limited, Crymych, Dyfed, Britain) in underwear  
and barefoot by an experienced assistant. The BMI was calculated as weight / height 
squared (kg/m2). Subjects were classified as obese using BMI gender- and age specific 
international cut-off levels (23). BMI was expressed as standard deviation score (SDS)  
for Dutch references using the LMS method (24). Pubertal development was recorded  
by the pediatrician according to Tanner (25). 
Mixed meal tolerance test
The children were asked to consume a daily amount of at least 150g carbohydrates three 
days prior to the mixed meal tolerance test and to continue their normal daily physical 
activities. The day before the test the subjects were asked not to consume any food  
or drinks after 10 pm, with the exception of tap water. On the morning of the mixed meal 
tolerance test the fasting state was verbally confirmed by the participant and a parent. 
A catheter was placed in an antecubital vein for blood sampling. Fasting blood samples 
were taken twice with a 15 minutes interval (t=-15 and t=0). After the second fasting blood 
sample was taken, the participants received a mixed meal bolus of 200mL (Nutridrink 
Yoghurt Style, Nutricia, Zoetermeer, The Netherlands). The mixed meal bolus consisted  
of 49% carbohydrates, 35% lipids and 16% proteins, with a total caloric content of 300 kcal. 
After the consumption of the mixed meal bolus, blood samples were taken two more times 
with a 15 minutes interval (t=15 and t=30) and four times with 30 minutes intervals (t=60, 
t=90, t=120 and t=150). Blood samples were analyzed for total ghrelin, PYY, GLP-1, glucose 
and insulin. 
Laboratory analysis
Tubes for blood collection of GLP-1, PYY and ghrelin and the inhibitor dipeptidyl peptidase 
IV (DPP-IV) (Linco Research, St. Charles, MO, USA) were placed on ice. Immediately after 
blood sampling, DPP-IV was added to tubes for measurement of GLP-1 and PYY to 
prevent degradation of these hormones. Blood samples for GLP-1, PYY and ghrelin were 
centrifuged within one hour after sampling and stored at -80ºC until analyzed. Baseline 
and T2 samples were analyzed in the same batches for all three hormones. Serum GLP-1 
concentrations were measured by a highly-specific enzyme-linked immunosorbent assay 
(human active GLP-1 ELISA Kit EGLP-35K, Linco Research, St. Charles, MO, USA; intra-assay 
coefficient of variation 8 ± 4.8%; inter-assay coefficient of variation 7.4 ± 1.1%; sensitivity 
2pM/L). PYY(3-36) concentration was determined by human radioimmunoassay (RIA)  
(PYY-67HK RIA Kit A 0.056, LincoResearch, St. Charles, MO, USA; intra-assay coefficient  
of variation 5.5-8.5%; inter-assay coefficient of variation 2.9-9.4%; accuracy 86.9± 5.2%). 
Total serum ghrelin was determined by human RIA as well (Ghrelin Total RIA GHRT-89HK Kit 
A 0.056 MBQ, Linco Research, St. Charles, MO, USA; intra-assay coefficient of variation  
0.9-1.3%; inter-assay coefficient of variation 6.2-7.8%; sensitivity 30 pg/mL). 
Glucose was analyzed from lithium heparine plasma by the glucose-oxydase method 
with the Unicel DxC 800 (Beckman Coulter, Woerden, the Netherlands). Plasma insulin 
concentration was measured by RIA (DSL-1600, Beckman Coulter, Woerden,  
the Netherlands; intra-assay coefficient of variation 4.5-8.3%; inter-assay coefficient of 
variation 4.7-12.2%; sensitivity 1.3μU/mL). An index for insulin resistance was calculated 
according to the Homeostasis Assessment Model for insulin resistance (HOMA-IR) formula: 
(fasting insulin (μU/mL) x fasting glucose (mmol/L)) / 22.5 (26). 
66
statistical analysis
The analysis was performed using the Statistical Package for Social Science SPSS,  
version 17.0 for Windows (SPSS Inc., Chicago, IL, USA) and the level of significance was set 
at p<0.05. Data were checked for normality before analysis, using descriptive statistics 
for skewness, kurtosis and Shapiro-Wilk test. The outcome variables for insulin were 
transformed to the natural logarithm. Data were expressed as mean ± standard deviation 
(continuous variables) and as count and percentage (categorical variables) unless 
otherwise defined. Values for the area under the curve (AUC) of 165 min (from t=-15  
to t=150 min) were calculated according to the trapezoid rule.
Paired t-tests were used to explore difference of the outcome variables after treatment,  
in total 16 paired t-tests were performed. A separate ANCOVA analysis was performed  
to determine if the change in AUC of the gut hormones over time (T2 vs. T1) was effected 
by gender, age, pubertal stage or change in BMI-SDS. In the ANCOVA analysis the changes 
in AUC of the gut hormones were used as dependent variables, time (T2 vs. T1) and gender 
as fixed variables and age, pubertal stage and change in BMI-SDS as covariates. 
R e s u Lt s
subjects
Forty-one subjects (18M/22F; age: 13.3 ± 2.0 years) were enrolled in the study,  
and 36 children completed both study occasions. One subject withdrew before all  
baseline measurements were completed, two discontinued treatment and two did not 
show up at T2 for personal reasons. No significant difference in baseline BMI-SDS or age 
was observed between completers (4.2 ± 0.7 SDS; 13.3 ± 1.8 years) and noncompleters  
(4.3 ± 0.3; 13.3 ± 3.1 years). Results are presented for the 36 children completing both  
study occasions (18M/18F).
Anthropometry and Metabolic parameters 
Changes between both study occasions in anthropometry and metabolic parameters 
are shown in table 2. A significant reduction of BMI-SDS was found after 3 months 
multidisciplinary lifestyle treatment. 
Fasting plasma glucose and insulin concentrations (and consequently HOMA-IR) were 
similar at baseline (T1) and after treatment (T2). The AUC of plasma glucose and insulin 
concentrations in response to the meal was also not affected by intervention (Figure 1).
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figure 1: Plasma levels of insulin in response to a mixed meal at baseline (T1) 
vs. after intervention (T2)
VARiABLes BAseLine (t1) AfteR (t2) P-VALue*
BMI-SDS 4.2 ± 0.7 4.0 ± 0.9 0.003
HOMA-IR 4.2 ± 2.5 4.1 ± 3.0 NS
Glucose (fasting) (mmol/L) 5.2 ± 0.4 5.3 ± 0.4 NS
Glucose AUC (165 min × mmol/L) 905 ± 67 896 ± 86 NS
Insulin (fasting) (mU/L) 18.0 ± 10.7 17.4 ± 12.5 NS
Insulin AUC (165 min × U/L)† 10.3 ± 6.1 11.0 ± 8.0 NS
Ghrelin (fasting) (pg/mL) 612 ± 143 641 ± 144 NS
Ghrelin AUC (165 min × pg/L)† 92.3 ± 18.3 97.9 ± 18.2 0.006
PYY (fasting) (pg/mL) 90.2 ± 34.6 95.5 ± 32.8 NS
PYY AUC (165 min × pg/L) 16.3 ± 4.6 15.3 ± 5.0 NS
GLP-1 (fasting) (pM/L) 2.6 ± 0.9 2.5 ± 0.9 NS
GLP-1 AUC (165 min × pM/L) 567 ± 192 552 ± 197 NS
* p-value T2 vs. T1 (paired t-test)
table 2: Clinical and physiological parameters of the subjects with complete data (N=36)
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Gut hormones
The ghrelin AUC in response to the meal were slightly, but significantly increased after 
treatment. Fasting levels were not significantly affected (Figure 2). The treatment did not 
affect either fasting or postprandial plasma GLP-1 and PYY concentrations (Figures 3  
and 4). 
The ANCOVA analysis for change of circulating ghrelin and PYY levels between the  
two study occasions showed that the change in BMI-SDS during the study period was  
a significant covariate (p<0.01 and p=0.01 respectively). This finding suggests that weight 
loss affects the plasma PYY concentration. Gender, age and pubertal stage were  
no significant covariates.
The Effect of Multidisciplinary Lifestyle Intervention on the Pre- 











































figure 2: Plasma levels of ghrelin in response to a mixed meal at baseline (T1) 
vs. after intervention (T2)
figure 3: Plasma levels of GLP-1 in response to a mixed meal at baseline (T1) 
vs. after intervention (T2)
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D i s C u s s i O n
A 3 months multidisciplinary lifestyle intervention in obese children reduces adiposity 
(BMI-SDS) and elevates plasma ghrelin levels in response to a meal. In contrast, it does not 
affect circulating PYY and GLP-1 concentrations in fasting condition nor in response to 
food intake. Notably, changes of ghrelin and PYY AUC were significantly influenced by  
the change of BMI-SDS, which suggests that the production of these gut peptides is 
sensitive to body weight (change). We speculate that the impact of our intervention on BMI 
was too modest to reach statistical significance for the difference between average levels. 
Various studies have shown an increase of fasting plasma ghrelin levels after weight loss 
in obese children (8;10;13). However, the amount of weight lost was substantially greater 
in these studies than in ours. Other studies in which weight loss was more modest did not 
observe significant changes of fasting circulating ghrelin levels either (5;14).  
Interestingly, the change of plasma ghrelin concentrations was significantly and inversely 
associated with the change of BMI-SDS, which confirms that body weight (or caloric 
restriction) does influence ghrelin levels. This suggests that the effect of our intervention 
on weight reduction was too small to affect average fasting circulating ghrelin.  
It has been suggested that weight loss achieved by dietary or exercise treatment initiates 
compensatory changes in appetite and energy expenditure that hinders maintenance 
of the reduced body weight (4;5). Ghrelin release increases before a meal to initiate food 
intake (4;27). Thus, it is conceivable that higher (fasting) ghrelin concentrations in response 
to weight loss set off a greater hunger signal, which obviously renders the treatment goal 
more difficult to reach. 
It is unclear why serum ghrelin levels are low in obese children. Perhaps overfeeding  
is involved (feeding dampens ghrelin release) and the metabolic changes associated with 
obesity, such as insulin resistance (4). Indeed, a previous study revealed that the change of 
HOMA-IR after weight loss correlates inversely with the change in plasma ghrelin in obese 


















figure 4: Plasma levels of PYY in response to a mixed meal at baseline (T1) 
vs. after intervention (T2)
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GLP-1 and PYY are gut peptides produced in response to food intake. Both peptides 
provide a satiety signal to the brain to terminate eating (4). Fasting plasma concentrations 
of either peptide were reported to be normal (9;15-18) or reduced (19;20) in obese 
children, whereas postprandial levels are consistently lower (15;20;21). We show that 
modest weight reduction does not have an impact on fasting or postprandial GLP-1  
and PYY levels in obese children. This is in apparent contrast to the results of the very few 
previous studies evaluating the effect of weight loss on plasma gut hormone levels in 
children. Substantial weight loss (≥0.5 BMI-SDS) appears to be accompanied by an increase 
in fasting PYY (19) and (surprisingly) a decrease in (fasting) GLP-1 (15;18). 
It is important to emphasize that our multidisciplinary lifestyle treatment resulted  
in a statistically significant but only modest weight reduction. It is therefore conceivable 
that a more substantial average weight reduction of ≥ 0.5 BMI-SDS would have had more 
explicit effects on (average) gut hormone concentrations. This postulate is supported 
by other studies, but also by our own data showing that the amount of weight loss is 
correlated with counterregulatory changes of plasma ghrelin and PYY concentrations, 
which can contribute to the difficulties that patients encounter when they try to lose 
weight. Thus, GLP-1 analogues or dipeptidyl-peptidase IV inhibitors may help obese 
children to lose weight in response to lifestyle measures. 
In conclusion, only a few studies so far have evaluated the effect of weight reduction  
on (postprandial) PYY, GLP-1 or ghrelin concentrations in children with obesity. We show 
that modest weight reduction by lifestyle intervention slightly elevates ghrelin levels, 
whereas it does not affect PYY or GLP-1 concentrations. 
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A B s t R AC t
Purpose
Childhood obesity can have a huge impact on both somatic as well as on psychosocial 
functioning. The aim of this study was to evaluate the effect of multidisciplinary treatment 
on obesity and Health Related Quality of Life (HRQOL).
Methods
Obese children were randomized to a multidisciplinary treatment (n=40, body mass index 
(BMI)-SDS; 4.2±0.7, age;13.3±2.0) or standard care (n=39, BMI-SDS 4.3±0.7, age;13.1±1.9). 
At baseline (T0), after 3 months (T1) of treatment and after 1-year follow-up (T2), data were 
collected for BMI-SDS and 2 European based validated questionnaires for assessing HRQOL 
(KIDSCREEN, DISABKIDS). Data of normal weight control group was collected once  
for comparison of HRQOL.
Results
At T0 obese children showed significantly lower HRQOL compared to their normal weight 
peers (p=0.02). A significantly reduced BMI-SDS was found for the intervention vs. obese 
control group at T1 (4.0±0.9 vs. 4.2±0.7, p=0.02) and T2 (3.8±1.1 vs. 4.2±0.7, p=0.03). 
HRQOL in the intervention group was improved at T2 compared to T0 (mean [95%CI]; 
86.8[83.3-90.3] vs. 80.2[76.5-83.8], p<0.05), and unchanged in the obese control group. 
Parents reported a lower HRQOL for their obese children than the children themselves, 
with inter-class correlation coefficients for agreement varying between 0.669-0.847  
for total HRQOL.
Conclusion
HRQOL is more impaired in obese children compared to their normal weight counterparts 
and parents reported a lower HRQOL than their children. Multidisciplinary treatment  
is effective in reducing BMI-SDS and improving HRQOL after 1-year follow-up. 
trial Registration 
http://www.controlled-trials.com/ISRCTN36146436.
key words: Health related quality of life; obesity; weight loss; children; adolescents; 
treatment; parents 
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i n t R O D u C t i O n
During the last three decades the prevalence of childhood obesity has increased 
dramatically in Western countries, with the Netherlands not making an exception. 
Consequence of the rising prevalence of childhood obesity is an earlier appearance  
of co-morbidities such as type 2 diabetes mellitus and cardiovascular diseases [1,2]. 
Besides these physiological consequences, obesity can also have adverse consequences 
for psychosocial well-being [3,4]. Research has revealed that children with obesity show 
impaired self-esteem and lower scores for Health Related Quality of Life (HRQOL) with 
regard to physical functioning [3], indicating that obese children experience a burden of 
their overweight status both in their physical performance as well as in their self-esteem. 
Furthermore, peer victimization of obese adolescents has been associated with low self-
esteem, body dissatisfaction and social isolation [4]. Some authors even suggested that  
the HRQOL of severely obese children is comparable to that of children with cancer [5]. 
It appears that the HRQOL of obese children is particularly impaired concerning social 
and physical functioning in relation to the degree of overweight [3,6-11]. Children with 
obesity experience less social support from either their family or peers, and perceive more 
discomfort from their body weight on mobility in everyday life. Conflicting results have 
been reported concerning the effect of obesity on the psychological domain of HRQOL. 
While some investigators have found a weak [9] to moderate [8] association between 
obesity and the psychological domain of HRQOL, others reported no relationship at all 
[11,12]. The studies in which associations were observed were carried out in treatment 
seeking obese samples [8,9]. In obese children in community settings no adverse effect  
of their obesity on the psychological well-being was observed [11,12]. 
With respect to the parents’ perspective on psychological QOL, parents view their children 
as having greater impairments in emotional functioning than children report themselves 
[9,12]. Indeed, studies examining the agreement between a child self-report and a parent 
proxy report showed consistently lower HRQOL scores for all domains from parent proxy 
assessment than from child self-report [7,12]. The reason for this difference is not yet  
clear [13].
 
The observations that childhood obesity has multifaceted consequences in both  
the physical and psychological area [1-4] has led to an increased inclusion of psychological 
aspects in the treatment of childhood obesity, apart from existing physical activity and 
nutritional advices. Reducing body weight for height (expressed as body mass index,  
kg/m2 (BMI)) as well as improving HRQOL is the aim of most of these multidisciplinary 
treatments of children with obesity. The effects of such lifestyle interventions on 
maintenance of weight loss, however, are only small to moderate [14,15].  
Furthermore, conflicting results have been reported on the effects of multidisciplinary 
treatment on HRQOL in obese children, probably due to the use of different outcomes  
for HRQOL. Some studies have reported increased HRQOL in all QOL variables after short-
term multidisciplinary treatment, assessed by both a QOL questionnaire and a Pictorial 
Representation of Illness and Self Measure (PRISM) [16] or by means of a disease-specific 
quality of life measure [17]. Others, using the more general Pediatric Quality of Life 
Inventory (PedsQOL) [18] or the KINDL (German questionnaire for measuring quality of life 
in children and adolescents) [19], reported improvement in some of the QOL domains,  
but not in the psychological domain.
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There is a need for further documenting the short- and long-term HRQOL of children 
receiving multidisciplinary treatment for obesity. Therefore, the primary goal of the current 
study was to assess the effect of a multidisciplinary cognitive behavioral treatment, 
focused on reducing BMI and improving HRQOL in obese children, assessed by both  
self-report and parent proxy report. 
M e t H O D s :
study Design and setting
This study is part of a randomized clinical trial on the effect of a multidisciplinary cognitive 
behavioral treatment on childhood obesity. For full details of the protocol the reader 
is referred to our previous report [20]. Here the effects of the treatment on HRQOL 
immediately after 3 months treatment and after 1 year are presented. Newly presented 
children with obesity according to Cole’s reference values [21] aged 8-17 years, living in or 
close to the Hague and referred to a pediatrician for their obesity, were invited  
to participate.
Obese children who met inclusion criteria were stratified by gender and ethnicity (‘North 
European’ and ‘Other’) and randomized to the intervention (n=41) or control group (n=40) 
according to coin-tossing (figure 1). In order to obtain a similar size of the intervention 
and control groups, blocked randomization was applied with an allocation ratio of 1:1. 
Randomization was carried out by a member of the team who did not take part in the 
treatment. The children in the intervention group were divided into smaller groups of 10, 
depending on the child’s age. Potential participants were excluded if their knowledge of 
the Dutch language was insufficient. Other exclusion criteria were use of medication that 
might have an effect on weight loss, medical co-morbidities that could affect participation 
(e.g. hypothyroidism, high dose of glucocorticoids, diabetes mellitus) or previous 
enrollment in another cognitive behavioral treatment program with the focus on reducing 
obesity. To enable comparison of the HRQOL data of the obese children with normal 
weight peers, 34 healthy age, gender and ethnicity matched children with normal weight, 
recruited by the youth health services (Jeugd GGD Haaglanden), were examined once. 
This study was conducted in agreement with the ‘Declaration of Helsinki’. Approval was 
obtained from a regional medical ethical committee South West Holland. All parents and 
children gave their written informed consent.
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Multidisciplinary cognitive behavioral treatment 
The multidisciplinary cognitive behavioral treatment of the intervention group consisted 
of a screening phase, followed by an intensive phase of three months and booster sessions 
thereafter for a total period of two years. In the screening phase the children with their 
parents were seen at two separate occasions individually by a dietitian (45 minutes/ 
occasion), a child-physiotherapist (45 minutes/occasion), a child-psychologist (90 minutes/ 
occasion) and once by a social worker (90 minutes).
During the screening phase a dietician provided nutritional advice on reducing caloric 
intake and, more importantly, on learning healthy eating behavior. A 3-day dietary recall 
(1 weekend day included) was used to get more insight in dietary habits of the children. 
Information was provided about nutrition and healthy eating behavior according to the 
traffic light nutritional list [22]. The traffic light nutritional list identifies several main food 
groups (fruits, vegetables, grains, milk and other dairy products, meat, fish, and others). 
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figure 1: Flow diagram of participants through the study for the primary outcome 
measure (BMI-SDS)
108 Assessed for eligibility and invited to participate
Refused consent (n=27)
81 Underwent randomization
1 Refused measures at T1 1 Refused measures at T1
2 Discontinued intervention 3 Withdraw for measures at T2
2 refused measures at T2 3 No measures at T2
41 Assigned to Intervention group 40 Assigned to Control group
32 Were included for analysis at T3 35 Were included for analysis at T3
4 lost to follow-up 1 Withdraw
36 Were included for analysis at T2 33 Were included for analysis at T2
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Foods within each group are color-coded reflecting the caloric density per average 
serving and Dutch standards for healthy nutrition. The colors are green for “go”, orange for 
“approach with caution”, and red for “stop”. A child-physiotherapist evaluated the physical 
activity level of the children in the intervention group, based on a physical activity 3-days 
recall (1 weekend day included). The information from this recall was used for advice 
on how to increase and optimize physical activity during everyday life and to reduce 
sedentary activities. The role of the child psychologist was to help the children not only  
to reduce weight by learning cognitive behavioral techniques, but also to deal with  
and accept their own body. 
The intensive phase of the treatment consisted of 7 group meetings for the children,  
5 separate parent meetings and 1 meeting for parents together with their children. 
Meetings of 2½ hours per meeting were given biweekly. The main focus of the first two 
meetings with the children was on nutritional information of energy balance and healthy 
eating. During the remaining meetings with the children, several cognitive behavioral 
techniques were taught on self-control, coping and self-image, in order to maintain 
long-term lifestyle change and body weight reduction. The parent meetings addressed 
the topics of motivation for treatment of their children, including information on healthy 
nutrition, setting boundaries and how to help their children by giving positive feedback.
The control group was given an initial advice on physical activity and nutrition.  
After 1 year the children in the control group were offered to participate in the 
multidisciplinary cognitive behavioral treatment. The normal weight control group  
was measured only once at the beginning of the study.
Primary outcome
Data from the obese subjects were collected at baseline (T0), after the three months 
treatment (T1) and 1 year after baseline (T2). Weight to the nearest of 0.1 kg was measured 
using an electronic scale (SECA 911, Vogel & Halke, Hamburg, Germany) and height to 
the nearest of 0.1 cm with a stadiometer (Holtain, limited, Crymych, Dyfed, Britain) in 
underwear and barefoot. BMI was calculated as weight / height squared (kg/m2). 
Subjects were classified as obese using BMI gender- and age specific international cut-off 
levels [21]. BMI was expressed as a standard deviation score (SDS) for Dutch references[23]. 
The 1980 reference data for weight and height were used to obtain a realistic view  
on the degree of obesity without data being biased by the increased prevalence rate  
of childhood obesity.
secondary outcomes 
The Health Related Quality of Life (HRQOL) of the children was determined by a generic 
questionnaire (KIDSCREEN) and a questionnaire for chronic conditions (DISABKIDS).  
The KIDSCREEN questionnaire was used to assess differences in HRQOL between obese 
and normal weight peers. The DISABKIDS questionnaire was used to evaluate the effect  
of the treatment on HRQOL in the obese children and their parents. 
The KIDSCREEN questionnaire is suitable for children aged between 8-18 years and both  
a child as well as a parent proxy version are available. In this study only the child version 
was used to compare obese children with the children in the normal weight control group. 
The KIDSCREEN contains 52 questions addressing 10 domains of quality of life. 
82
These domains are: QOL-physical, QOL-psychological, QOL-mood, QOL-self-perception, 
QOL-autonomy, QOL-parents, QOL-peers, QOL-school, QOL-bullying, QOL-financial. Each 
domain contains 3-7 items. Questions can be answered by choosing from a 5-point scale: 
options: never (1), almost never/ seldom, average/ sometimes, quite often, always (5). After 
adjusting the negative items, the total and domains scores of the questionnaire  
are expressed as a percentage between 0-100, with a higher percentage reflecting  
a better HRQOL. The KIDSCREEN questionnaire has demonstrated a Cronbach α reliability 
coefficient ranging between .77 and .89 for all ten domains [24], which is considered as  
a good reliability.
The DISABKIDS questionnaire is suitable for children aged between 4-18 years. In this study 
the DISABKIDS was used to compare the HRQOL of the obese children in the intervention 
group with the HRQOL of the children in the obese control group. Because the children’s 
scores on HRQOL questionnaires are often higher than parental scores, we also used  
the parent version of the DISABKIDS questionnaire. The DISABKIDS questionnaire contains 
37 questions divided over 6 subscales of 6-7 items each. In this study only the first five 
subscales (31 items) were used to calculate the HRQOL, because the last subscale focuses 
on medication use related to a disease. The five subscales that were included in this study 
are: QOL-life, QOL-day, QOL-feeling, QOL-other and QOL-friends. The questions could be 
answered by choosing from a 5-point scale: never (1), almost never/ seldom, average/ 
sometimes, quite often, always (5). After adjusting the negative items, the total and 
domains scores of the questionnaire were expressed as a percentage between 0-100,  
with a higher percentage reflecting a better HRQOL. The Cronbach α reliability coefficient 
of the child version of the DISABKIDS ranges between .70 to.87 for children aged 8-12 years 
and between .77 to.90 for children aged 13-16 years [24]. To our knowledge no results  
have been published of reliability coefficients concerning the parent proxy version  
of the DISABKIDS questionnaire.
statistical analysis
Intention-to-treat analyses were performed using the Statistical Package for Social  
Science SPSS, version 17.0 for Windows (SPSS Inc., Chicago, IL, USA). An independent  
t-test was used to compare the obese children vs. the normal weight children at baseline. 
For comparison of the HRQOL domains at baseline between obese and normal weight 
children ANOVA analysis was used with Bonferroni correction for multiple testing and 
group as fixed variable. The total HRQOL score was analyzed separately. To determine the 
effect of time on the outcome variables within the groups ANOVA for repeated measures 
was performed for the domains with Bonferroni correction and for the total HRQOL and 
BMI-SDS separately with time as fixed variable. The effect of treatment on the total HRQOL 
scores and BMI-SDS were analyzed with ANOVAs for repeated measures with group and 
time as fixed variables. MANOVAs for repeated measures were used to determine the effect 
of treatment at T1 and T2 on HRQOL domains, both for the child and parent proxy report 
separately. In addition, an inter-class correlation coefficient (ICC) was used to describe the 
relationship between the child and parent proxy report for the total HRQOL scores and per 
domain. The level of significance for all analyses was set at p<0.05. 
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R e s u Lt s
treatment effect on BMi-sDs
The ANCOVA for the effect of the multidisciplinary treatment on BMI-SDS at T1 and 
T2, controlling for baseline measures, was statistically significant (p=0.02 and p=0.03, 
respectively), showing a reduction of BMI-SDS in the intervention group and no change  
in BMI-SDS in the obese control group.
HRQOL in obese vs. normal weight children
The results of HRQOL for the KIDSCREEN questionnaire for the intervention group, obese 
control group and normal weight control group at baseline are shown in table 1.  
No significant difference was found for age and gender between the obese and normal 
weight children. Total HRQOL was significantly lower in the obese group compared to  
the normal weight controls: (mean (SE) 83.0(0.9) vs. 86.7(1.1), p=0.02, respectively),  
as well as for the domains QOL-physical (mean (SE) 70.7(1.9) vs. 82.9(2.4), p<0.01, 
respectively) and QOL-self-perception (mean (SE) 69.0(1.9) vs. 85.891.9), p<0.01, 
respectively), indicating that obese children have impaired HRQOL, in particular  
for physical functioning and self-perception. 
Variable intervention group Obese control group normal weight group
M [95% Ci] M [95% Ci] M [95% Ci]
Gender (M/f) 18/22 19/20 14/20
Age (years) 13.3 ± 2.0 13.1± 1.9 13.2 ± 2.4
BMI-SDS 4.2 ± 0.7‡ 4.3 ± 0.6‡ 0.5 ±1.4
QOL-Tot-Kid 81.4 [78.4;84.4]‡ 84.7 [82.4;86.9]‡ 86.7 [78.4;84.4]
QOL-physical 66.3 [61.5;71.0]‡ 75.2 [69.5;80.9]‡ 82.9 [78.0;87.8]
QOL-psychological 86.3 [82.9;89.8] 88.2 [84.1;92.3] 90.1 [87.3;92.9]
QOL-mood 83.9 [79.4;88.4] 84.7 [81.3;88.1] 87.1 [83.5;92.9]
QOL-self-perception 69.1 [63.7;82.9]‡ 68.9 [63.4;74.3]‡ 85.8 [819;90.8]
QOL-autonomy 83.1 [77.9;88.2] 87.3 [83.3;91.3] 87.3 [83.9;89.7]
QOL-parents 89.6 [85.6;93.5] 92.4 [90.0;94.9] 91.9 [89.0;90.7]
QOL-peers 79.6 [73.7;85.4] 85.0 [81.0;89.1] 85.0 [80.9;94.7]
QOL-school 87.0 [83.2;90.8] 92.2 [85.7;92.2]‡ 82.4 [78.4;86.4]
QOL-bullying 86.3 [81.1;91.6] 88.7 [83.8;93.6] 90.9 [87.7;94.0]
QOL-financial 77.6 [69.9;85.3] 86.1 [80.2;92.0] 82.7 [76.3;89.2]
* The mean difference compared to obese control group is significant at the 0.05 level
‡ The mean difference compared to normal weight control group at the 0.05 level
table 1: HRQOL of obese children vs. normal weight children at baseline  
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treatment effect on HRQOL
The results of the DISABKIDS questionnaire in the intervention and obese control groups  
at T0, T1 and T2 are shown in table 2. At baseline no significant difference was found  
for total HRQOL nor for the domains between the intervention and obese control group. 
ANOVA of repeated measures for measuring differences in HRQOL over time within  
both groups, showed a significant increase of total HRQOL, QOL-life and QOL-feeling 
for the child report from T0 to T2 only for the intervention group. For the parent proxy 
a significant increase in total HRQOL as well as QOL-day was found for the intervention 
group at T2 vs. T0. The (M)ANOVAs for repeated measures for assessing differences in  
the effect of treatment over time on total HRQOL and the domains did not show  
a significant difference in mean change between the two groups, neither for the child 
report nor for the parent part of the questionnaire.
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Variable Child Report Parent Proxy
intervention group Obese control group intervention group Obese control group
M [95% Ci] M [95% Ci] M [95% Ci] M [95% Ci]
t0 (baseline)
Age (years) 13.3 ± 2.0 13.1 ± 1.9
BMI-SDS 4.2 ± 0.7 4.3 ± 0.7
QOL-Tot-Dis 80.2 [76.5-83.8] 82.8 [78.4;87.2] 74.1 [70.2;78.0] 79.8 [74.6;85.0]
QOL-life 82.2 [77.7;86.8] 84.7 [80.7;88.8] 84.8 [80.9;88.8] 86.4 [82.9;89.8]
QOL-day 81.5 [77.0-86.0]‡ 81.8 [76.3;87.2]‡ 70.9 [67.4;86.0] 73.6 [68.6;78.7]
QOL-feeling 76.0 [70.6;74.3]‡ 78.8 [73.7;84.0]‡ 68.8 [63.2;74.5] 71.1 [65.2;76.9]
QOL-others 87.5 [83.6;91.3] 87.0 [82.4;91.7] 82.9 [78.1;87.7] 83.7 [78.9;88.6]
QOL-friends 74.9 [70.7;79.0] 77.7 [73.6;81.9] 72.1 [66.9;77.3] 76.6 [71.4;81.7]
t1 (3 months)
Age (years) 13.8 ± 1.8 13.4 ± 1.9
BMI-SDS 4.0 ± 0.9* 4.2 ± 0.7
QOL-Tot-Dis 84.1 [80.8-87.5] 83.9 [79.3;88.6] 77.9 [73.5;82.3] 80.5 [75.8;85.2]
QOL-life 87.4 [82.9;91.8] 88.0 [84.2;91.9] 84.9 [79.4;90.5] 86.3 [82.5;90.2]
QOL-day 82.5 [78.1-86.9]‡ 85.8 [80.7;90.8]‡ 73.6 [69.3;86.9] 74.0 [67.4;80.7]
QOL-feeling 84.5 [79.5;77.9]‡ 80.1 [73.9;86.5] 73.0 [66.3;79.7] 75.3 [69.0;81.6]
QOL-others 89.1 [84.8;93.3] 87.7 [83.0;92.5] 81.9 [76.2;87.5] 86.3 [81.1;91.5]
QOL-friends 76.7 [72.6;80.7] 79.9 [74.6;85.2] 72.4 [67.4;77.5] 79.8 [74.3;85.3]
t2 (1-year follow-up)
Age (years) 14.4 ± 1.8 14.0 ± 2.0
BMI-SDS 3.8 ± 1.1* 4.2 ± 0.7
QOL-Tot-Dis 86.8 [83.3-90.3]*‡ 85.6 [81.2;89.9] 82.9 [78.9;87.0]* 81.6 [75.9;87.4]
QOL-life 90.1 [87.1;93.1]* 87.3 [83.5;91.0] 88.9 [85.7;92.2] 88.3 [83.8;92.8]
QOL-day 83.7 [78.5-88.8] 85.4 [80.7;90.0]‡ 78.4 [73.9;88.8]* 78.8 [72.1;85.6]
QOL-feeling 87.0 [81.2;82.9]*‡ 83.3 [77.8;88.8]‡ 77.8 [71.8;83.8] 78.8 [73.6;84.0]
QOL-others 92.4 [89.1;95.7]‡ 91.3 [87.8;94.7]‡ 86.7 [82.7;90.7] 84.8 [78.9;90.7]
QOL-friends 78.9 [73.7;84.1] 80.4 [75.7;85.2] 78.9 [73.7;84.1] 77.8 [71.2;84.5]
* The mean difference compared to baseline is significant at the 0.05 level
‡ The mean difference compared to parent proxy perspective at the 0.05 level
table 2: Short-term and Long-term results of DISABKIDS HRQOL
85
The effect of family-based multidisciplinary cognitive behavioral 
treatment on Health Related Quality of Life in Childhood obesity 5
Child self report vs. parent proxy report
The inter-class correlation coefficient for the total HRQOL of the DISABKIDS questionnaire 
between child and parent report was 0.669 at baseline, 0.705 at T1 and 0.847 at T2.  
Those ICCs indicate that conformity in the scores of HRQOL between children and parents 
increased over time from 66.9% to 84.7% agreement. For the separate domains of  
the DISABKIDS questionnaire a poor to moderate ICC was found varying between  
0.484 (QOL-day) – 0.640 (QOL-others) at baseline, between 0.492 (QOL-feeling) – 0.756 
(QOL-friends) at T1 and between 0.553 (QOL-others) – 0.773 (QOL-friends) at T2,  
with lower scores found in the parent compared to child report.
D i s C u s s i O n
This study aimed at evaluating the effect of a multidisciplinary cognitive behavioral 
treatment on BMI-SDS and HRQOL in obese children compared to standard care. 
Improvements in BMI-SDS were found after 3 months of multidisciplinary treatment  
and 12 months follow-up, with no changes in obese children receiving standard care. 
Concerning the short-term treatment effect on adiposity, similar conclusions were made  
in numerous previous reports on multidisciplinary lifestyle interventions [25-28].  
Contrasting findings by others were however reported with regard to the long-term 
treatment effects on adiposity [25]. In contrast to our findings, in the latter study  
the reduced body weight after treatment was not further reduced in half of the subjects 
and even significantly increased in remaining half during the follow-up period [25]. 
effect of Obesity on HRQOL
With respect to the impact of obesity on HRQOL, we found significantly lower total  
HRQOL scores in the obese vs. the normal weight children as well as lower domain scores 
of physical activity and self-perception. These findings confirm the results of others,  
also reporting lower total HRQOL in obese compared to normal weight children [6,9,29]. 
The lower QOL-physical activity score found in the obese vs. normal weight children  
in the current study was in agreement with other studies as well [6,9,10,30].  
However, observations on differences between obese and normal weight peers for  
the psychological and the social domain of HRQOL are more diverse. While impaired  
social functioning was found in obese children by most other investigators [6,9,11],  
we observed significantly lower scores for the psychological domain in obese children. 
These contradictory findings might be attributed to differences in the definition of  
the HRQOL domains in the questionnaires used. So far many studies [6,7,9-11] have used 
the Pediatric Quality of Life Inventory (PedsQL 4.0) questionnaire for comparing  
HRQOL between obese and normal weight children, which is only partly comparable  
to the KIDSCREEN questionnaire. 
short-term treatment effect on HRQOL
Immediately after treatment HRQOL scores had already improved, though not significantly. 
In contrast, in previous studies a significant short-term effect on HRQOL scores was 
observed after multidisciplinary treatment [16,17,19]. This difference might be explained 
by the different methods used to determine HRQOL, or by the different treatment mode. 
While we used a validated generic questionnaire, in these prior studies also a (non-
validated) obesity specific QOL questionnaire was used, and findings were reported after 
in-patient instead of out-patient treatment [16,17,19]. It is conceivable that a disease 
specific instrument is more sensitive to short-term change in HRQOL since it targets 
the areas critical for obesity. This difference in short-term sensitivity for treatment effect 
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between questionnaires, emphasizes the need for a obesity-specific module of DISABKIDS, 
as is available for several other diseases. In addition, the amount of weight-loss after the 
in-patient interventions was larger than observed in our patients. We speculate that that 
the short-term weight loss in our study was not pronounced enough to cause a statistically 
significant change in HRQOL. 
Long-term treatment effect on HRQOL
Exploring the long-term effect of multidisciplinary treatment on HRQOL, we found  
a significant improvement after 12 months follow-up in the intervention group.  
At this time a better total HRQOL was found, as well as improved QOL for the specific 
domains of QOL-life and QOL-feeling.
Improved HRQOL after follow-up and not yet immediately after treatment have been 
reported in a previous study [17]. In this study two multidisciplinary treatment regimens 
for obese children were compared, one with and the other without the inclusion of 
psychological counseling. The improved HRQOL was only observed in the treatment group 
with psychological counseling. Taken together, these findings indicate that inclusion of 
psychological interventions and face-to-face contact with health professionals continued 
during follow-up seems to be important for the long-term improvement of HRQOL  
of obese children. 
Child self report vs. parent proxy report
Comparing the children’s self-reports with the parent proxy reports, we found significantly 
lower HRQOL scores reported by the parents. In addition, a poor to moderate inter-class 
correlation coefficient was found between the child and parent reports. This finding is 
in conformity with previous studies [7,9,12] that also reported lower parent proxy scores 
compared to child self-reports with poor parent-child agreement in a treatment seeking 
obese sample [12]. It is important to emphasize that previous studies found a similar ICC 
between normal weight children and their parents [9]. So parents of treatment seeking 
obese children are possibly more worried about their child than the children themselves 
or they may have a limited understanding of their child’s experienced HRQOL. It is also 
possible that parents view HRQOL from a broader perspective than children do and are 
therefore better able to compare the HRQOL of their obese child with that of normal 
weight children. Either way, by using both children’s self-reports and parent proxy  
reports a more complete impression of HRQOL is gained. 
Limitations of the study
One of the limitations of this study is that our study population consisted of treatment 
seeking obese children, who may experience more impairment on their HRQOL than their 
obese peers in the community. Previous studies have shown varying results, some showing 
no significant differences between treatment seeking and community-derived obese 
children [9]. Other studies have reported lower scores of HRQOL in a treatment seeking 
sample [8,11]. A second limitation of the current study is that we did not use the PedQL 
4.0 or an obesity-specific HRQOL questionnaire, used by most previous studies. Using the 
DISABKIDS and KIDSCREEN questionnaires, however, could also be regarded a strength, 
since this questionnaire is a European based and well validated questionnaire.
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strengths of the study
One important strength of the study is the randomized controlled design, studying 
the longitudinal effect of a multidisciplinary cognitive behavioral treatment on HRQOL 
in obese children compared to standard care. Whereas most other studies only report 
cross-sectional data or short-term treatment effect after non-randomized interventions, 
we randomly assigned our patients to an intervention and control group. By including 
a randomly allocated control group it was possible to detect if HRQOL further declined 
or remained stable when children were not treated. Additionally, the use of both self-
reports as well as parent proxy reports in this study gives more information on the 
HRQOL of children and can help to determine at which level treatment can be improved. 
Furthermore, by assessing both self-report and parent proxy report it is possible to 
compare our results with previous studies using either one or both forms of report. 
CO n C Lu s i O n
In conclusion, the obese children in our study showed significantly lower HRQOL 
compared to their normal weight peers. In particularly for physical functioning,  
lower HRQOL scores were found in obese children and agreement between child and 
parent report was moderate, with lower scores found by parent proxy report. In addition, 
obese children receiving multidisciplinary treatment showed a significant reduction of 
their BMI-SDS as well as significantly improved HRQOL after 1 year follow-up. However, 
although a significant weight reduction was found in the intervention group, the majority 
of the children were still obese after the multidisciplinary treatment. HRQOL assessment  
in children with obesity can help understanding the impact of obesity on everyday life  
and how it affects the child’s well-being. Results of these HRQOL measurements  
can be used to improve treatment of obese children; for example the most impaired 
domains of HRQOL can be considered in greatest need of extra attention in the 
multidisciplinary treatment. In addition, more longitudinal studies on the effect  
of multidisciplinary treatment on HRQOL in obese children are needed to explore  
how treatment programs for obesity can be improved. 
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Components of the Metabolic 




A B s t R AC t: 
Background/Aims
The usefulness of the concept of the Metabolic Syndrome (MS) in its current form  
was recently questioned and its association with insulin resistance is unknown.  
We assessed whether a multivariate model based on all components of MS expressed  
on a continuous scale would be a better predictor of a common marker of insulin 
resistance than the current dichotomous MS definitions (Cook, de Ferranti, IDF). 
Methods
Data from 78 obese Dutch teenagers (13.0±2.1yr) were used for model development  
and the model was validated in 40 obese Hindustani children (12.6±2.0yr).  
The MS components and HOMA-IR were expressed as standard deviation scores (SDS), 
based on gender- and age-specific reference values. 
Results
The prevalence of MS was 36% (Cook), 65% (De Ferranti) and 18% (IDF), with low mutual 
agreement. None of these dichotomous models were significant predictors for increased 
HOMA-IR SDS. The multivariate model incorporating the MS components expressed  
as SDS explained 58% of the variance of increased HOMA-IR SDS. In the validation group 
the predicted and observed HOMA-IR SDS (2.4±1.2 vs. 2.6±2.2) did not differ significantly. 
Conclusion
A multivariate prediction model based on the MS components expressed as SDS  
has a good predictive value for increased HOMA-IR SDS. 
keywords: metabolic syndrome; children; prediction model; obesity; HOMA. 
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i n t R O D u C t i O n
Since the 1980s the prevalence of childhood obesity has increased dramatically worldwide 
(1-3). For example, in the Netherlands the prevalence of overweight and obesity in children 
(4-16 years) has more than tripled (from 3.9 to 14.5%) in boys in the period 1980-2003  
and more than doubled (from 6.9 to 17.5%) in girls, and is still increasing (4). Several studies 
have demonstrated that 50% of children and 80% of adolescents with obesity become 
obese adults (5;6). In adults, obesity is associated with a higher risk for developing type 
2 diabetes mellitus and cardiovascular disease (7-10), and in children and in adolescents 
obesity is associated with increased prevalence of hypertension, dyslipidemia and 
impaired glucose metabolism (11-14). The clustering of these risk factors was first reported 
in 1988 by Reaven as Syndrome X. Originally, the syndrome focused on the association 
with hyperinsulinemia and insulin resistance (15) , also in obese children (16).  
Furthermore, longitudinal studies have suggested that the Syndrome X in children  
and adolescents predicts the developing cardiovascular disease and type 2 diabetes 
mellitus in adulthood life (13;17-19). Therefore the syndrome was renamed as Metabolic 
Syndrome (MS). 
 
For the pediatric age group several definitions have been proposed, with modifications  
of adult definitions most commonly used (16;20-24). Hyperinsulinenia is not included  
in most definitions. Consensus on the cut-off levels of the separate components of the MS  
for pediatric patients has still been difficult to obtain. One of the reasons is that in children 
and adolescents these cut-off levels are not only influenced by gender, but also by age and 
pubertal stage (20;22;25). Previous studies have shown that even in the same study group 
the prevalence of the MS varies considerably depending on the definition chosen (25-27). 
Furthermore, the dichotomous concept of the MS was recently questioned (28;29),  
and a recent WHO report has expressed doubt on the usefulness of the concept of MS  
in its current form (29). There is no accepted central underlying mechanism of the MS, 
although insulin resistance (10) and central obesity (30) have both been proposed  
to play this role.
In view of this current opinion on the limited usefulness of the MS, new strategies  
to overcome at least part of its limitations are needed. Insulin resistance is an independent 
predictor of cardiovascular disease and type 2 diabetes (31-34). In addition is was recently 
shown to be the best predictor of MS in first-degree relatives with type 2 diabetes (35).  
This study aimed to: 1) investigating the predictive value of the traditional parameters 
of MS as assessed by current dichotomous definitions of MS (Cook et al. (20), de Ferranti 
et al (22) and IDF (36;37)) for insulin resistance; and 2) develop a multivariate model 
incorporating all components of the MS expressed as standard deviation scores (SDS)  
to predict insulin resistance in obese Dutch children, and validate this in an independent 
group of obese Hindustani children.
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M e t H O D s
subjects
Clinical data were collected of children with obesity (based on the cut-off level described 
by Cole et al. (1)) who were referred to two pediatric clinics (Juliana Children’s Hospital/
HagaHospital (JKZ), the Hague, and Leiden University Medical Center (LUMC), Leiden. 
The age range was limited to 10.0-18.0 years, since MS is difficult to determine in children 
younger than 10 years (36;37). Children were excluded when their obesity was caused by  
an underlying medical condition or medication use. For developing the prediction model 
for insulin resistance, patients were divided into two groups: the first group included 
children of Dutch ancestry (n=78) and the other group children of Hindustani origin 
(n=40). The prediction model was based on the Dutch children and validated in the 
Hindustani children. Ethnicity was determined according to self-reports by the parents.
Definitions of the Metabolic syndrome
The MS was defined according to the three most often used definitions for the pediatric 
age group by other research groups (Cook et al.(20), De Ferranti et al.(22), IDF(36;37)  
(Table 1)). The MS was considered present when three or more components were abnormal 
in the definitions of Cook and de Ferranti. According to the definition of the IDF, subjects 
were classified as MS when their waist circumference (WC) was increased and two or more 
of the other parameters were abnormal. In all definitions the Dutch gender- and age-
specific WC diagrams were used for classification of central obesity (38). In the definitions 
of both De Ferranti and Cook the age-, height- and gender-specific percentiles of  
the National High Blood Pressure Education Program (NHBPEP)(39) were used for blood 
pressure. In the definition of the IDF the adult criteria for hypertension were used. 
The three definitions used different cut-off levels for impaired fasting HDL and fasting 
triglycerides (TG). Cut-off levels for impaired fasting glucose (FG) are the same in  
the definitions of De Ferranti and Cook. The IDF definition uses a different cut-off level  
for impaired FG (Table 1). 
CRiteRiOn DefinitiOns
Cook et al.[20] De ferranti et al.[22] iDf[37]
≥3 of the 5 criteria below: ≥3 of the 5 criteria below: WC ≥ 90th percentile, 
age ≥10 yr and ≥2  
of the other 4 criteria:
Waist Circumference (cm) ≥ 90th percentile 
(age-, sex specific)
≥ 75th percentile 
(age-, sex specific)
≥ 90th percentile 
(age-, sex specific)
Blood Pressure (mmHg) ≥ 90th percentile 
(age-, sex-, height 
specific)
≥ 90th percentile 
(age-, sex-, height 
specific)
SBP ≥ 130 and/or  
DBP ≥ 85
HDL (mmol/L) HDL ≤ 1.04 HDL < 1.30 HDL < 1.03 
Triglycerides (mmol/L) TG ≥ 1.24 TG ≥ 1.1 TG ≥ 1.7 
Glucose Intolerance 
(mmol/L)
FG ≥ 6.1 FG ≥ 6.1 FG ≥ 5.6 
table 1: Definitions of the Metabolic Syndrome according to Cook, de Ferranti and IDF
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Measurements
Weight was measured to the nearest of 0.1 kg using an electronic scale (SECA 911,  
Vogel & Halke, Hamburg, Germany) and height to the nearest 0.1 cm with a stadiometer 
(Holtain, limited, Crymych, Dyfed, Britain) in underwear and barefoot. The Body Mass Index 
(BMI) was calculated as weight/height squared (kg/m2). Subjects were classified as obese 
using BMI international gender- and age-specific cut-off levels developed by Cole et al. (1). 
The WC (in cm) was measured with an anthropometric tape midway between the lower rib 
margin and the iliac crest at the end of gentle expiration. Blood pressure was determined 
in a relaxed sitting position measurement with an electronic device (Criton Dinamap,  
No. 8100), in duplicate; the last measurement was used for further analysis.
Laboratory analysis 
With the subject in the supine position, blood samples were taken by venipuncture  
after an overnight fast. Before blood sampling, the study participants and their parents 
were asked to confirm the fasting state. Fasting plasma HDL, TG and FG were collected 
with BD vacutainers (LH PST II Plus Blood Collection Tubes, BD Belliver Industrial Estate, 
Plymouth, UK). Plasma fasting insulin (FI) was sampled with Vacuette 2.5 mL Z Serum  
Sep Clot Activator (Greiner Bio-One GmbH, Kremsmüsterm Austria). Analysis for fasting 
plasma HDL, TG and FG was conducted by the hospital laboratory of the HagaHospital  
(The Hague, the Netherlands) and FI by the laboratory of the Leiden University Medical 
Center (Leiden, the Netherlands). HDL was analyzed by homogenic enzymatic colorimetry, 
TG by automatized colorimetry, all determined by bynchon Lx20 Pro/ unicel DXC 800 
(Beckman Couter, Brea, US) and FG was analyzed by the glucose-oxidase method.  
FI was analyzed by the Immulite 2500 immunoanalyser (Siemens healthcare Diagnostics, 
Deerfield, IL, US).
An index for insulin resistance was calculated according to the HOMA-IR formula: fasting 
insulin (μU/mL) x fasting glucose (mmol/L)) / 22.5 (40). Although a hyperinsulinemic-
euglycemic clamp is considered to be the golden standard for determining insulin 
resistance, the non-invasive HOMA-IR model is considered a useful tool to assess insulin 
resistance in epidemiologic studies (40). 
statistical analyses
The analysis was performed using the Statistical Package for Social Science (SPSS), 
version 17.0 for Windows (SPSS Inc., Chicago, IL, USA) and the level of significance was 
set at p<0.05. Data were checked for normality before analysis using descriptive statistics 
and histograms. Data are expressed mean ± standard deviation (continuous variables) 
and as count and percentage (categorical variables). Independent t-tests were used for 
comparison of the ‘Dutch’ and ‘Hindu’ subgroups with continuous data and the Chi-square 
test for comparison with categorical data. Standard deviation scores (SDS) were calculated 
for the individual parameters of the MS, based on gender- and age-specific reference 
values, for WC (38), HDL (41), TG (41), FG (42), systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) (43;44). Standard deviation scores for HOMA-IR (HOMA-IR SDS)  
were calculated, based on gender- and age-specific reference values (42). In order to test 
the agreement between the dichotomous definitions of MS the weighted kappa was used. 
The weighted kappa ranges between 1 (perfect agreement) and 0 (no agreement).  
In general values less than 0.40 indicate poor, between 0.41-0.60 indicate moderate, 
between 0.61-0.80 indicate good and above 0.81 very good agreement.
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To establish the predictive value of the three dichotomous definitions of the MS (Cook,  
de Ferranti, IDF) separate linear regression models were performed, with HOMA-IR SDS  
as dependent variable. The prediction model with the SDSs of the individual components 
of MS was developed by means of multiple linear regression in the group of Dutch 
children. Because fasting glucose is used to calculate the HOMA-IR, the model was also 
conducted without FG-SDS. The coefficients of the first model were used to calculate  
the predicted HOMA-IR SDS for all children. Differences between observed and predicted 
HOMA-IR SDS were expressed in terms of Studentized residuals. The residual is calculated 
as the observed HOMA-IR SDS minus the predicted HOMA-IR SDS for each observation, 
and the Studentized residual is the residual divided by its SE. For the validation of both 
models data was used from 40 Hindustani children, who fulfilled the inclusion criteria. 
Paired sample t-test was used to determine a significant difference between the observed 
and predicted HOMA-IR SDS in the Hindustani children. Pearson correlation was also used 
to assess the correlation between the observed and predicted HOMA-IR SDS in the model 
validation subgroup. 
R e s u Lt s
The characteristics of the 78 Dutch children (31 boys (40%)) studied and of the 40 
Hindustani children (16 boys (40%)) are listed in Table 2. There is a trend towards a younger 
age in the group with Hindustani children. The FG-SDS is significantly higher and a trend 






Age (years) 13.5 ± 2.1 12.6 ± 2.0 NS (0.06)
Weight (kg) 84.0 ± 17.5 80.8 ± 19.4 NS
Height (cm) 161.9 ± 9.8 157.7 ± 11.0 0.03
BMI (kg/m2) 31.7 ± 3.9 32.0 ± 4.3 NS NS
BMI-SDS 3.0 ± 0.7 3.1 ± 0.7 NS
WC (cm) 97.0 ± 10.6 91.6 ± 10.7 0.01
WC-SDS 4.4 ± 1.3 3.9 ± 1.2 NS (0.06)
SBP (mmHg) 125 ± 11 126 ± 12 NS
SBP-SDS 1.6 ± 1.0 1.8 ± 1.0 NS
DBP (mmHg) 66 ± 8.5 65 ± 9.6 NS
DBP-SDS -0.0 ± 0.8 0.1 ± 0.9 NS
HDL (mmol/L) 1.2 ± 0.3 1.1 ± 0.2 NS
HDL-SDS -0.8 ± 1.0 -0.9 ± 0.7 NS
TG (mmol/L) 1.2 ± 0.9 1.0 ± 0.4 NS
TG-SDS 0.3 ± 1.0 0.2 ± 0.5 NS
FG (mmol/L) 5.0 ± 0.4 5.2 ± 0.4 <0.01
FG-SDS -0.2 ± 1.0 0.3 ± 1.0 0.02
FI (mU/L) 17.2 ± 11.2 20.7 ± 10.3 NS
HOMA-IR index 3.9 ± 2.7 4.8 ± 2.4 NS (0.06)
HOMA-IR SDS 1.9 ± 2.5 2.6 ± 2.2 NS
* p-value < 0.05 is considered statistically significant, NS= not significant.
table 2: Subject characteristics of the Dutch group of obese children group used for 
constructing the model and of the Hindustani validation group 
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In the Dutch group the highest prevalence rate of the MS was found using the definition 
of De Ferranti (65%), followed by Cook (36%), and the lowest prevalence rate was found 
according to the IDF criteria (18%) (Table 3). The weighted Kappa, used to test the 
agreement between these definitions was 0.56 (Cook vs. IDF), 0.46 (De Ferranti vs. Cook) 
and 0.21 (De Ferranti vs. IDF), thus the agreement between these definitions was poor  
to moderate. Mean BMI-SDS in subjects with vs. without the MS according to the definition 
of De Ferranti was not significantly different (3.1 ± 0.8 SDS vs. 3.0 ± 0.7 SDS, respectively).  
A significantly higher BMI-SDS was found for children with vs. without the MS by Cook  
(3.3 ± 0.7 SDS vs. 2.8 ± 0.8 SDS, p=0.03) and by the IDF criteria (3.5 ± 0.8 SDS vs.  
2.9 ± 0.6 SDS, p=0.01).
Increased HOMA-IR SDS was not significantly predicted by the dichotomous definitions 
of MS. This is also reflected in the low explained variance in increased HOMA-IR SDS by 
the three definitions; 17.8% (2.3SE) according to De Ferranti, 16.3% (2.3SE) according to 
Cook and 16.1% (2.3SE) according to IDF. Because the risk is expressed as ‘present’ or ‘not 
present’, with no distinction in severity of increased metabolic risk, this finding indicates 
that by dichotomizing increased metabolic risk much predictive information is lost.
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≥3 of the 5 
criteria below:
28 (36) ≥3 of the 5 
criteria below:
51 (65) WC ≥  
90th percentile, 
age ≥10 yr and 
≥2 of the other 
4 criteria: 
14 (18)
WC ≥  
90th percentile 
78 (100) WC ≥  
75th percentile 
78 (100) WC ≥ 90th 
percentile
78 (100)
BP ≥  
90th percentile
50(64) BP ≥  
90th percentile
50 (64) SBP ≥ 130 
mmHg  
and/or  
DBP ≥ 85 
mmHg 
23 (30)
TG ≥  
1.24 mmol/L
23(30) TG ≥ 1.1 mmol/L 31 (40) TG ≥ 1.7 mmol/L 13 (17)
HDL ≤  
1.04 mmol/L 
22(28) HDL <  
1.30 mmol/L 
51 (65) HDL < 1.03 
mmol/L 
21 (27)
FG ≥  
6.1 mmol/L
1(1) FG ≥  
6.1 mmol/L
1 (1) FG ≥ 5.6 
mmol/L
4 (5)
table 3: Prevalence of the metabolic syndrome and the frequencies of its criteria according to 
the three proposed definitions
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The multiple linear regression model incorporating the SDSs of the individual components 
of the MS as predictive variables and HOMA-IR SDS as outcome variable is shown in Table 
4. The most important predictor of HOMA-IR SDS (apart from FG-SDS) is WC-SDS. The 
explained variance of the model with FG-SDS is 58%, with a standard error of 1.8 and is 
described by the following multiple linear regression equation: HOMA-IR SDS = 2.2 + 0.9 x 
Gender (male=0, female=1) –0.3 x Age (year) +1.0 x FG-SDS + 0.7 x WC-SDS - 0.8 x DBP-SDS 
+ 0.6 x SBP-SDS + 0.7 x TG-SDS – 0.2 × HDL-SDS.
The multiple linear regression equation for HOMA-IR SDS without FG-SDS in the model has 
an explained variance of 46%, with a standard error of 2.0 and can be described as follows: 
HOMA-IR SDS = - 0.8 + 0.8 x Gender (male=0, female=1) –0.2 x Age (year) +1.1 x WC-SDS - 
0.8 x DBP-SDS + 0.7 x SBP-SDS + 0.8 x TG-SDS – 0.3 × HDL-SDS. 
For the mathematical validation of both prediction models a Studentized residual plot  
is used to identify outliers, nonlinearity, and non-constant error variants in the prediction 
model. The observed randomly clustered observations imply that there is no heterogeneity 
in the Dutch group with respect to relevant importance of the different predictors  
(Figures 1A and 2A). The paired student t-test to determine the difference between 
observed HOMA-IR SDS (2.6 ± 2.2) and predicted HOMA-IR SDS (2.4 ± 1.2) in the Hindustani 
children was not statistically significant (p=0.550). This indicated that HOMA-IR SDS  
of these children can be predicted by the model for predicting HOMA-IR SDS,  
based on the data in the Dutch children. Also the correlation between the observed  
and the predicted HOMA-IR SDS in the Hindustani children is statistically significant 
(r=0.540, p<0.01). In addition, the plot of the Studentized residual vs. the predicted  
HOMA-IR SDS in the validation group (Figures 1B and 2B) showed a similar pattern  
of randomly clustered observations as in the plot of the Dutch group.
table 4: Prediction model for increased HOMA-IR SDS according to the enter procedure. 
Rank order is based on a backward procedure 
MODeL PReDiCtOR COeffiCient [ 95%Ci] RAnk
Linear Regression with  




FG-SDS 1.0 [0.3;1.6] 1
WC-SDS 0.7 [0.2;1.2] 2
DBP-SDS -0.8 [-1.7;0.1] 3
SBP-SDS 0.6 [-0.2;1.4] 4
TG-SDS 0.7 [-1.1;2.6] 5
HDL-SDS -0.2 [-0.9;0.5] 6
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figure 1: Studentized rediduals vs. predicted HOMA-IR SDS in the Dutch children with obesity 
(A) and the validation group (B) according to the derived prediction model including all SDSs of 























Regression Standardized Predicted HOMA-IR SDS
A
101
The Predictive Value of the Individual Components of 
the Metabolic Syndrome for Insulin Resistance in Obese Children 6
figure 2: Studentized rediduals vs predicted HOMA-IR SDS in the Dutch children with obesity 
(A) and the validation group (B) according to the derived prediction model including all SDSs  
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D i s C u s s i O n 
The results of our study demonstrate a different impact for the individual components  
of the metabolic syndrome (MS) on increased insulin resistance. The regression model  
with all the standard deviation scores of the individual components of MS in the model, 
showed an explained variance of 58%. From the individual variables of the MS,  
not included in the HOMA-IR index, the standard deviation score of WC provided to be  
the best predictor for increased insulin resistance, confirming the previously reported 
superior role of the WC in predicting health risk (45;46).
The predictive value of the dichotomous definition of the MS on increased HOMA-IR 
SDS was poor (16.1-17.8%) and not statistically significant. Furthermore, no significant 
difference was found for BMI-SDS between children with and without MS by the definition 
of De Ferranti, suggesting that this definition provides the least information on which child 
is most at risk.
It is now widely recognized that the definition of the MS in its current form has limitations. 
A major disadvantage of the MS definition is its dichotomous character. As pointed out  
by the WHO (29), dichotomization of a health risk makes it impossible to determine  
the absolute risk of a subject and to assess whether this health risk increases or decreases. 
In addition, in children the cut-off levels of the individual components of the proposed 
definitions of the MS are age-, and gender-dependent. Since no consensus exists on  
the optimal cut-off values for the parameters of the MS and reference values are often 
lacking for age and gender, prevalence rates are study design dependent. As a result, 
widely varying prevalence rates have been found, as shown by us (20-55%) and others  
(13-50%) (16;22;24-27;47;48) in the same study population, when different definitions  
are used. As a consequence it is difficult to compare the results of prevalence rates  
of the MS between different study populations. 
A previously suggested alternative for the dichotomization of the metabolic risk is to 
calculate a continuous metabolic risk score, including fat mass (DXA), waist circumference, 
BMI, HOMA-IR and systolic blood pressure (28). However, the metabolic risk score  
in this study was calculated by subtracting the sample’s mean from the individual mean,  
which was then divided by the standard deviation of the sample mean. By definition  
the mean score for metabolic risk of the study sample was zero. The sum of the sample-
based Z-scores was divided by the number of variables, included in the risk score.  
So again a relative risk is obtained which is only applicable for the studied sample  
at the time of data collection. Another problem not solved by this alternative approach,  
is that by using the average of the Z-scores a similar weight is given to the Z-scores  
of the individual components. In contrast, the frequency and impact of the specific 
components are probable not equivalent. 
To overcome these obstacles we propose to express the individual metabolic risk variables 
as standard deviation scores, based on gender- and age specific reference values.  
In this way changes can be detected easier, which provides the clinician with a long-term 
perspective on change in health risk. This will help the clinician in deciding about  
the frequency of consultations and the level of care to be provided to the child. 
Furthermore, by using a regression model to predict increased health risk, differences  
in the impact of the individual components of MS on health risk are taken into 
consideration. A similar approach was used by Ranke et al to predict growth velocity 
during growth hormone treatment based on a series of clinical parameters (49).  
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We determined the predictive value of the SDSs of the individual MS components on 
increased insulin resistance. As expected, we found a different impact for the individual 
MS parameters on increased HOMA-IR SDS. However, although this model showed a quite 
reasonable predictive value (58% with and 46% without FG-SDS), the predictive power of 
the presence and severity of the MS for type 2 diabetes mellitus in later years is unknown. 
Moreover, during childhood, it is known that the degree of insulin resistance varies,  
with many unknown influencing factors. For that reason, it is not unexpected that  
a substantial part of the variance in the prediction model remains unexplained. 
To validate our prediction model for increased HOMA-IR SDS, we used the data of  
a separate group of children meeting the same inclusion criteria, but of different ethnic 
origin. In this group the predicted and observed HOMA-IR SDSs were comparable and 
their correlation was statistically significant. Also the Studentized residual plot showed 
randomly clustered observations, implying no heterogeneity in the validation group with 
respect to relevant importance of the different predictors. These findings indicate that  
our prediction model may be useful for predicting increased HOMA-IR SDS in other groups 
of obese children. 
We are aware that our study has some limitations. The sample sizes of both groups  
were relatively small for constructing and validating a prediction model. However we feel 
that despite this limitation our study can offer a valuable contribution to the discussion  
on ways to improve the concept of the MS for predicting which obese child is most  
at risk for developing morbidity. Furthermore, data from a clinical sample of obese subjects 
may be influenced by selection and referral bias and may therefore not be representative 
for all obese children in the general population. However, obese children, referred to  
a pediatrician, are probable most at risk for developing obesity related co-morbidity.  
Future research with a larger sample size is recommended to validate and refine our model. 
In conclusion, the variation in prevalence rates for the MS between three dichotomous 
definitions in the same pediatric study population is high, and mutual agreement is poor. 
Since the individual parameters of the MS are age-dependent and gender-dependent  
they can better be expressed as SD scores than be compared with fixed cut-off levels.  
We developed a model for predicting increased insulin resistance, taken into 
considerations the different impact of the standardized components of the MS.  
We speculate that using such a model to predict obesity-related co-morbidities may prove 
superior to the current definitions, because it provides an indicator for the severity  
of MS and a tool for assessing amelioration or deterioration of metabolic risk factors  
in obese children and adolescents. 
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The general aim of the studies described in this thesis was the effect evaluation  
of a family-based multidisciplinary cognitive behavioral treatment on several domains 
related to childhood obesity compared to standard care. The primary outcome parameters 
were the treatment effect on total obesity (BMI-SDS) and abdominal obesity (WC-SDS). 
Other domains of interest were the effect of the above-mentioned treatment on glucose 
homeostasis, inflammatory state, secretion of gastrointestinal hormones involved in food 
regulation, physical fitness and Health Related Quality of Life (HRQOL). Furthermore,  
we aimed to evaluate the effect of the metabolic consequences of childhood obesity 
on increased health risk in terms of insulin resistance. In this chapter the results of these 
studies will be considered in a broader perspective. First the main findings of these studies 
will be reviewed in relation to the literature. Next, possible causes for the modest weight 
reduction after lifestyle interventions in the obese children will be discussed. Subsequently, 
the predictive value of impaired anthropometric and metabolic variables on future health 
risk will be addressed. This chapter will conclude with a discussion on clinical relevance  




R e s u Lt s  O f  M u Lt i D i s C i P L i n A Ry  CO G n i t i V e  
B e H AV i O R A L  t R e At M e n t  O f  O B e s e  C H i L D R e n
Childhood obesity is a worldwide expanding problem and now poses one of the greatest 
public health challenges for the next decades, along with its associated co-morbidities. 
In the battle against childhood obesity behavioral lifestyle interventions, combined with 
parental involvement, are preferred over standard care or self-help (1). The results of 
behavioral lifestyle interventions on obesity and associated co-morbidities are promising 
(2-7), however, the intermediate and long-term follow-up effects are uncertain (8;9). 
The results discussed in chapter 3 show a positive short-term (3 months), intermediate  
(1 year follow-up) and long-term (2 years follow-up) treatment effect on total obesity  
(BMI-SDS) as well as abdominal obesity (WC-SDS). This latter finding is of special 
importance, since it has previously been reported that health risk is increased by  
the combination of increased BMI-SDS alone and a WC > 90th percentile for age 
and gender, rather than by an increased BMI-SDS per se (10). In the same chapter 
we also showed that weight reduction after lifestyle treatment improved physical fitness, 
while a constant degree of obesity, as found in our obese control group, was associated 
with a significantly decreased physical fitness. This finding of an improved physical fitness 
in our intervention group is not only important for their health status, but also for their 
psychological wellbeing. 
In chapter 5 we showed that obese children experience a lower HRQOL especially for the 
domains related to physical fitness and self-perception, as was reported previously (11-14). 
It is important to mention that, although obese children significantly reduce their adiposity 
after lifestyle treatment, they remain on average still obese. In view of this, findings like  
a reduced WC-SDS, improved physical fitness and better HRQOL after modest weight loss 
are important. Measurement of waist circumference, a simple test for physical fitness  
and the completion of a short HRQOL questionnaire during follow-up visits of obese 
children and their family after treatment could be motivating and helpful tools,  
both for pediatricians and general practitioners.
In addition, although modest weight reduction by lifestyle intervention slightly elevates 
ghrelin levels, as shown in chapter 4, it did not affect PYY or GLP-1 concentrations.  
Also the increased inflammatory state in the obese children compared to normal peers  
was not significantly altered after lifestyle treatment in our study (chapter 3),  
while others did find a significant treatment effect (7;15). It is therefore conceivable  
that a more substantial average weight reduction of ≥ 0.5 BMI-SDS would have had  






P O s s i B L e  C Au s e s  O f  M O D e s t  R e s u Lt s  
O f  L i f e s t y L e  i n t e R V e n t i O n s
It is known that numerous factors contribute to obesity, including genetic, environmental, 
biochemical, psychological and physiological factors. This complex multi-factorial causality 
underlying childhood adiposity, makes it unlikely that a single treatment will be successful 
for all children with obesity. Also, the socio-economic status and ethnic diversity should be 
taken into consideration in future attempts to improve the treatment of childhood obesity. 
To improve long-term follow-up results, it may be considered to offer treated pre-pubertal 
children a modified lifestyle intervention again, once they enter puberty.
Besides modest weight reduction as a result of multidisciplinary lifestyle interventions, 
another known problem in this kind of weight reduction treatment programs is  
the high dropout rate during treatment and follow-up (8). In our study repeated booster 
sessions were scheduled during the whole follow-up period of 2 years, but we also found 
decreasing adherence of the participants over time, with the highest dropout rate during 
the first 12 months (8 children). In the second year of the intervention only one additional 
child was lost to follow-up. To overcome this problem, an increased frequency of booster 
sessions, such as every other month during the first year and 3 additional ones during  
the second year of follow-up might be beneficial, partly because of the effect of social peer 
pressure in the treatment groups. Also frequent email communication and an attractive 
interactive website where children can ask questions answered by health professionals  
and chat with their obese peers might be helpful.
In spite of these additional strategies to improve treatment results by motivating  
obese children to change their lifestyle, the real problem lays in the difficulty to change  
the environment of these children. Historically, a fat child meant a healthy child,  
one who was likely to survive the rigors of undernourishment and infections (16). 
Moreover, people had to deal with fluctuating food availability during the year  
and from year to year. In this light it was beneficial to evolve a mechanism to protect man  
from extinction during long periods of hunger. In addition, human energy regulating 
systems are extraordinarily precise under normal conditions and a positive energy balance 
of only 120 kcal per day will produce a 50 kg increase in body weight over a period of 
10 years (16). Thus, any factor that raises energy intake or decreases energy expenditure 
by even a small amount will cause obesity in the long-term (16). In today’s society of 
industrialized countries, not only energy intake has increased, but also food is always 
available without periods of shortage. Furthermore, a sedentary lifestyle has become more 
common. In view of this, the rapidly increasing prevalence rates of childhood obesity in 
a genetically stable population during the last few decades, can be largely attributed to 
adverse environmental factors in combination with an evolutionary conserved tendency 
to favor obesity. It is, therefore, unrealistically optimistic to expect that the battle against 
childhood obesity can be won without fundamental changes in social environment.
114
e f f e C t  O f  C H i L D H O O D  O B e s i t y  O n  A D u Lt  H e A Lt H
Childhood obesity is of particular interest, because of possible long-term associations  
with adult overweight and subsequently associated morbidity. There is strong evidence 
that obesity during childhood increases the risk of obesity during adulthood considerably 
(17). In addition, a large population based cohort study found that higher childhood 
(7-13 years) BMI values elevated the risk of developing coronary heart disease (CHD) in 
adulthood (≥ 25 years) (18). Furthermore, in chapter 6 we showed that increased WC-SDS 
and FG-SDS were significant predictors for increased HOMA-IR SDS. So, unless aggressive 
new treatment modalities will be developed to change obesity trends, present-day 
childhood obesity will have a substantial effect on public health, reaching far into  
the future.
The CHD Policy Model, in which the prevalence of 35-year-old obese adults in 2020  
is estimated, is used to predict that the present epidemic of adolescent obesity in  
the United States will substantially increase future rates of adult CHD (19). In addition, 
there is already evidence that recent North American birth cohorts not only are becoming 
obese in greater number at a given age, but also earlier in their life course compared to 
the birth cohorts from the previous decades (20). Consequently this will lead to a greater 
cumulative exposure to excess weight over their lifetime, which will, most likely,  
have profound implications for future rates of obesity related co-morbidity (20).  
It is conceivable that a similar trend will occur in other western countries, dealing with  
an increased prevalence rate of childhood obesity during the last few decades.  
Importantly, the majority of overweight and obese adults in our time did not have 
overweight as a child. Therefore, the adult health risk profile of today’s overweight  
youth might be different from that of earlier generations.
The epidemic proportions of childhood obesity support the idea of a population-based 
preventive approach. It is important to study, from a population-based view, the impact of 
lifestyle interventions on all children with obesity participating in these intervention  
and not only on those who complete the lifestyle intervention.
f u t u R e  P e R s P e C t i V e s
The prevalence of obesity among children has been increasing since the 1980’s,  
with little indication of a decrease or reversal of this trend (21). This has led to  
the prediction that today’s generation of children may be the first for whom life expectancy 
falls (22). Although the knowledge of childhood obesity and its health consequences 
increases every year, many questions concerning best preventive and treatment 
possibilities remain still open. Preventing and treating childhood obesity has proven to 
be challenging and treatment options include lifestyle interventions (with or without 
psychological strategies), as well as pharmaceutical interventions and bariatric surgery 






With today’s knowledge, behavioral lifestyle interventions seem to be the preferred 
treatment strategy for obese children. Although most trials studying the effect of such 
interventions on childhood obesity show modest weight reducing results, the effect  
is statistically significant and clinically meaningful in reducing obesity and associated  
co-morbidity (1). In severely obese adolescents with obesity related co-morbidities,  
a more intensive weight loss therapy might be appropriate. 
In a recent systematic review the role of pharmacotherapy in the treatment of childhood 
obesity was described, based on a meta-analysis (24). The pooled effect of both 
Sibutramine and Orlistat lead to a significant reduction in BMI of 2.4 kg/m2 (CI 1.8, 
3.1 kg/m2) and 0.7 kg/m2 (CI 0.3,1.2 kg/m2), respectively, compared to placebo over 
12 months (24). However, Sibutramine is no longer an option for young people with 
obesity in Europe as the license has been withdrawn because of cardiovascular safety 
concerns regarding its use in the adult population, although it still has a restricted license 
for use in the United States (25). Moreover, most drugs do not produce permanent changes 
in physiology or behavior, raising the prospect of life-long treatment (25). In addition, 
treatment effects of registered anti-obesity medication on weight reduction are modest 
as well (24). Taken together, adding medication as an adjunct to the lifestyle intervention 
can be considered, but this approach needs to be carefully weighted against the potential 
adverse effects (1). 
Also the decision to advise bariatric surgery in obese adolescents should be taken with 
care. It can only be considered if intensive lifestyle interventions, possibly in combination 
with anti-obesity medication, have failed. In general, the laparoscopic adjusted gastric 
banding (LAGB) or Roux-en-Y gastric bypass (RYGB) lead to substantial weight loss in 
adults (26). Reliable data in obese adolescents on the effect of such procedures on weight 
reduction and the severity of side effects and complications of the procedures are lacking. 
Evidence so far is based on clinical observations. Short-term benefit of surgery in severely 
obese adolescent has been shown, but long-term follow-up data are sparse (25).  
Adverse events reported after surgery range from mild malnutrition to more 
severe complications, including severe malnutrition, gastrointestinal bleeding, and 
gastrointestinal obstruction (26). Therefore, in view of present knowledge, the surgical 
approach should be considered as a last resort for severely obese adolescents (27).
Future longitudinal research has to focus mainly on which child will benefit from which 
kind of intervention to develop specific individualized therapies, as well as straightforward 
changes of social environment by the government and local authorities in order to 
“detoxify” it. Meanwhile it is advised to try to motivate obese children to change their 
lifestyle and eating pattern, with the help of a dietician. Assessment of WC, physical  
fitness and HRQOL will assist the health professionals to achieve a better insight  
in the development of health risk of the obese child and may motivate the obese child  
and family during treatment. 
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Childhood obesity has become a global problem. The rapidly increasing prevalence  
of childhood obesity observed during the last few decades is assumed to be mostly  
the result of environmental factors such as increased food consumption and a change  
from a more physically active lifestyle to a more sedentary one. Childhood obesity affects 
self-esteem and has negative consequences on cognitive and social development.  
Obese children tend to become obese adults with increased risk for developing 
cardiovascular complications, type 2 diabetes mellitus and psychosocial problems. 
Additionally, the secretion of several gastrointestinal hormones, responsible for appetite 
and food intake, is altered in obese subjects. Understanding the mechanisms that control 
energy balance and fuel flux in children with obesity is of paramount importance for  
the design of effective strategies to combat this health hazard. So far, the most appropriate 
treatment for obese children is a multidisciplinary cognitive behavioral intervention.  
The results of such interventions immediately after treatment are promising.  





The main objective of the studies presented in this thesis is the effect evaluation  
of a family-based cognitive behavioral multidisciplinary lifestyle treatment on childhood 
obesity. The intervention aims to establish long-term weight reduction and stabilization, 
reduction of obesity-related health consequences and improvement of self-image  
by change of lifestyle and education using cognitive behavioral techniques.
In this longitudinal clinical trial newly presented children with obesity (8-17 years old)  
were randomly attributed to an intervention or control group, both consisting of  
40 children. The intervention was carried out in groups of 8-11 children, and consisted of  
7 and 5 separate group meetings for the children and their parents, respectively,  
and 1 joint group meeting of 2½ hours. Main topics were education on nutrition,  
self-control techniques, social skills, physical activity and improvement of self-esteem.  
The control group was given advice on physical activity and nutrition. For comparison  
with non-obese peers, additional data were collected from 34 normal-weight children,  
8-17 years old.
In chapter 2 the study protocol of the family-based multidisciplinary cognitive behavioral 
treatment is extensively described.
The treatment effect of this family-based multidisciplinary cognitive behavioral lifestyle 
intervention on adiposity, physical fitness, glucose homeostasis and inflammatory state in 
obese children compared to standard care is presented in chapter 3. Our intensive lifestyle 
intervention resulted in a modest long-term reduction of both total and abdominal 
adiposity accompanied by improved physical fitness, while unchanged adiposity in 
untreated controls led to decreased physical fitness and deterioration of insulin sensitivity.  
No effect was observed on inflammatory markers.
In chapter 4 it is shown that the observed weight reduction did not affect gut hormone 
concentrations, except that it significantly increased the postprandial ghrelin response 
after treatment. 
Chapter 5 shows that Health Related Quality of Life (HRQOL) is significantly impaired 
in obese children concerning the physical activity and self-perception domains compared 
to their normal weight peers. The parents of obese children reported significantly lower 
HRQOL scores for their children compared to the estimates made by their children 
themselves. We found that our multidisciplinary lifestyle treatment was effective  
in improving the HRQOL of the obese children after 1 year. 
In chapter 6 we propose an alternative for the definition of the metabolic syndrome, 
since the usefulness of its current dichotomous form is questioned. We suggest the use  
of a prediction model for increased insulin resistance (defined as HOMA-IR), in which  
the different degree of the impact of the individual components of the metabolic 
syndrome is considered. In this chapter we show that this multivariate prediction model 
based on the individual components of the metabolic syndrome expressed as standard 










Obesitas (vetzucht) bij kinderen is gedurende de afgelopen decennia een groeiend  
en wereldwijd probleem geworden. De snel toenemende prevalentie van obesitas  
op de kinderleeftijd is voornamelijk te wijten aan verandering in omgevingsfactoren,  
zoals een toegenomen voedselconsumptie en de verandering van een actieve naar  
een meer inactieve levenswijze. 
Obesitas heeft negatieve gevolgen voor het zelfvertrouwen en voor de cognitieve  
en sociale ontwikkeling van het kind. Daarnaast is gebleken dat dikke kinderen vaak  
dik blijven als volwassene, wat op zijn beurt samengaat met een verhoogd risico op  
het ontwikkelen van cardiovasculaire complicaties, diabetes mellitus type 2  
en psychosociale problemen. Tevens wordt bij dikke volwassenen en kinderen  
een verandering waargenomen in de secretie van diverse maagdarm-hormonen,  
die een rol spelen in het reguleren van de voedselinname. Het is van groot belang  
om inzicht te verkrijgen in de mechanismen die verantwoordelijk zijn voor het regelen  
van de energiebalans, om zo effectieve strategieën te kunnen ontwikkelen voor  
de behandeling van dit belangrijke gezondheidsprobleem. 
De tot nu toe meest geschikt gebleken behandeling voor obesitas bij kinderen  
is een multidisciplinaire cognitieve gedragsinterventie. Over de middellange- en lange-
termijn effecten van een dergelijke behandeling bestaat echter nog onduidelijkheid.  
Het primaire doel van de in dit proefschrift beschreven studies is de effect-evaluatie  
van een multidisciplinair behandelprogramma bij kinderen met obesitas. Het doel van  
de interventie was het bewerkstelligen van een blijvende gewichtreductie en  
een verbetering van het gezondheidsrisicoprofiel en het zelfvertrouwen door middel van  
een verandering van leefstijl. 
In dit longitudinale klinische onderzoeksproject zijn recent verwezen kinderen met 
obesitas, in de leeftijd van 8-17 jaar, via randomisatie verdeeld in een interventie- en 
controlegroep van elk 40 kinderen. De interventie werd aangeboden in groepen van  
8-11 deelnemers. Er waren 7 aparte bijeenkomsten van 2½ uur voor de kinderen,  
5 voor hun ouders en 1 voor kinderen en ouders samen. Gedurende de groeps-
bijeenkomsten werden een gezond voedingspatroon en een lichamelijk actieve leefstijl 
aangeleerd middels cognitieve gedragsveranderings-technieken. De controlegroep 
werd alleen geadviseerd om meer te bewegen en gezonder te eten. In een additionele 
groep van 34 kinderen (8-17 jaar) met een normaal gewicht werden gegevens verzameld 
waarmee de gegevens in beide groepen obese kinderen konden worden vergeleken. 
Een uitgebreide beschrijving van het studieprotocol van het multidisciplinaire 
behandelprogramma is weergegeven in hoofdstuk 2.
Het effect van deze multidisciplinaire behandeling op de mate van obesitas,  
lichamelijke fitheid, glucose-homeostase en ontstekingsparameters, in vergelijking met 
het effect van standaard zorg, wordt beschreven in hoofdstuk 3. Ons multidisciplinair 
behandelprogramma liet een bescheiden effect zien op de mate van obesitas en 
lichamelijke fitheid. In de controlegroep werd echter geen enkel effect op de mate van 
obesitas waargenomen en een verslechtering van de lichamelijke fitheid en insuline-
gevoeligheid. Er was geen waarneembare verandering van het behandelprogramma  
op ontstekingsparameters in het bloed. 
Samenvatting
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In hoofdstuk 4 laten we zien dat de waargenomen gewichtsreductie na behandeling 
geen effect had op de nuchtere bloedspiegel van PYY en GLP-1, noch op de verandering 
van de concentratie van deze darmhormonen na een testmaaltijd. De stijging van de 
bloedspiegel van ghrelin na een testmaaltijd nam echter significant toe na behandeling.
In hoofdstuk 5 is te lezen dat kinderen met obesitas hun eigen kwaliteit van leven 
significant slechter beoordeelden dan hun leeftijdgenootjes met een normaal gewicht. 
Daarnaast beoordeelden de ouders van obese kinderen de kwaliteit van leven van 
hun kind als lager dan de kinderen zelf deden. In dit hoofdstuk laten we zien dat ons 
multidisciplinair behandelprogramma de kwaliteit van leven van de obese kinderen  
na 1 jaar significant heeft verbeterd. 
In hoofdstuk 6 geven we een alternatief voor de definitie van het metabool syndroom, 
aangezien de bruikbaarheid van de huidige dichotome vorm bekritiseerd wordt.  
Ons voorstel is om een predictiemodel voor insuline-resistentie (HOMA-IR) te gebruiken, 
waarbij rekening wordt gehouden met het verschil in impact van de individuele 
gestandaardiseerde componenten van het metabool syndroom. In dit hoofdstuk tonen we 
aan dat zo’n model de obesitas-gerelateerde comorbiditeit beter voorspelt dan de huidige 
dichotome definitie van het metabool syndroom.
Samenvatting
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Het dankwoord is, ondanks dat het onder het ‘niet wetenschappelijke’ deel van  
het proefschrift valt, wel een van de belangrijkste onderdelen ervan, en tevens  
het moeilijkste. Het belangrijkste omdat zonder de inzet, steun en motivering van velen, 
dit proefschrift waarschijnlijk niet tot stand was gekomen. Het moeilijkste omdat ik 
allen wil bedanken maar niet iedereen bij naam kan noemen. Bovendien wil ik niemand 
vergeten. Daarom eerst in algemene zin mijn dank aan iedereen die mij de afgelopen jaren 
op uiteenlopende wijzen gemotiveerd heeft bij het schrijven van dit proefschrift.  
Toch wil ik ook een aantal personen bij naam bedanken.
Allereerst de kinderen en ouders die bereid zijn geweest om aan de in dit proefschrift 
beschreven studies mee te werken. Zij hebben regelmatig vele uren voor testen 
doorgebracht in het JKZ. Ik heb het gevoel een band met jullie opgebouwd te hebben  
en ben nog steeds ontroerd als ik weer een van jullie tegenkom en jullie mij vol 
enthousiasme begroeten en vertellen hoe het met jullie gaat. En me ook in alle eerlijkheid 
melden wat jullie moeilijk vinden en hoe jullie daarmee omgaan. Heel veel dank  
voor jullie inzet!
Natuurlijk mijn directe, dagelijkse begeleider gedurende het promotietraject,  
Mieke Houdijk. Mieke, tijdens onze eerste ontmoeting had ik meteen het gevoel dat  
er een klik tussen ons was. Wat ik zocht was precies wat jij voor ogen had. Bij thuiskomst 
had ik niet het gevoel op sollicitatiegesprek geweest te zijn. Gelukkig is dit gevoel 
gebleven, ook tijdens de intensieve onderzoeksjaren. Ik heb altijd prettig met je 
samengewerkt. Daarvoor heel veel dank.
Jan Maarten Wit, tijdens het begin van mijn promotie was ik waarschijnlijk wat onzichtbaar 
voor je. Maar in de laatste fase van mijn promotietraject is het contact steeds intensiever 
geworden. De afgelopen maanden bijna dagelijks. Ik heb het gevoel dat ik gedurende  
mijn promotietraject ben gegroeid, mede dankzij jouw begeleiding. Hoewel het hier om 
een figuurlijke groei gaat, moet dat toch goed voelen voor een kinderarts-endocrinoloog 
met als ‘groot’ aandachtsgebied groei(stoornissen). Mijn hartelijke dank!
Hanno Pijl, jij was precies de juiste aanvulling als begeleider naast Mieke en Jan Maarten.  
Jij kon de zaken vaak net vanuit een andere perspectief bekijken of aanvullen. Ik heb ook 
met plezier naar jouw oratierede geluisterd en deze is een inspiratiebron voor de discussie 
van dit proefschrift geweest. Hartelijk dank dat je je, ondanks je drukke eigen agenda,  
toch betrokken voelde bij mijn promotie.
Sasja, ook jou wil ik bedanken voor de prettige samenwerking. Vooraf dacht ik dat het stuk 
over kwaliteit van leven het lastigst zou zijn om te schrijven. Maar door jouw enthousiasme 
heb ik erg veel plezier beleefd aan het tot stand komen ervan en ben ik ook erg blij  
met het eindresultaat. Bedankt voor je kritische blik en prettige manier van sturen  
tijdens het schrijven van dit artikel.
Maar zonder de inzet van de twee ‘Haagse Maatjes’ behandelteams had ik het onderzoek 
niet kunnen uitvoeren. Het is zeker niet makkelijk om de levensstijl te veranderen van  
een individu, laat staan van een heel gezin. Jullie hebben altijd naar de individuele situatie 
gekeken van het kind en het gezin en op die manier geprobeerd hen te motiveren  
hun levensstijl te veranderen. Daarvoor petje af!!
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Onderzoek doe je nooit alleen, daarom wil ik de personen van de diverse afdelingen  
in zowel het JKZ als het LUMC bedanken voor hun bijdragen en enthousiaste inzet:  
zonder jullie hulp was ik niet ver gekomen. 
Allereerst de ‘Dagbehandeling’ in het JKZ (Tineke, Annet, Gerda, Caroline, Agnes, Paula): 
bedankt voor gedurende meer dan 2 jaar, 2 dagen per week intensief testen. We zijn vele 
obstakels tegengekomen, maar zijn er altijd overheen gekomen. De ‘Longfunctie’  
(Jeanne, Nellie en Laura): bedankt dat ik altijd in overleg gebruik heb kunnen maken  
van de inspanningsruimte voor de maximaal testen en natuurlijk voor jullie input  
en gezelligheid! Ook wil ik bedanken het CKCL in het RKZ, met name Jacqueline,  
het CKCL in het LUMC, met name Jolanda, en het Endo lab in het LUMC, met name Chris. 
Nauwgezetheid en vooruitdenken zijn vereist voor onderzoek met parameters  
in het bloed. 
En natuurlijk is er ook een dankwoord voor de kinderartsen en arts-assistenten, Arianne, 
Mariëtte, Nicolien en Gabriëlle, voor hun betrokkenheid en interesse gedurende  
de ruim vier jaar in het JKZ. 
Om goed te kunnen functioneren is er een balans tussen werk en privé nodig.  
Hoewel ik niet altijd even veel tijd had om af te spreken, heb ik altijd wel begrip en steun 
ondervonden van familie en vrienden. Peggy en Kim: jullie weten als geen ander  
hoe het aanvoelt, en een enkel woord was vaak genoeg, waarna we de rest van de tijd 
konden bijkletsen. Lisanne, Kristin, Marjon, Karin, Margreet, Sandra (nu op afstand),  
Astrid en Natascha bedankt voor de gezellige etentjes, het hardlopen, en de weekeind-
koffie/ lunch; jullie zorgden dat de balans in evenwicht bleef! 
Maar het belang van een goed nest onderschat ik niet, papa en mama bedankt!  
Jullie hebben me altijd gestimuleerd het beste uit mezelf te halen. Papa, jouw plezier  
in leren en mama jouw eigenschap je echt ergens in vast te bijten, heeft mij gestimuleerd 
om na het afronden van mijn studie een promotieonderzoek op te pakken. Papa, ik weet 
nog goed dat we tijdens een boswandeling een keer over promotieonderzoek hebben 
gesproken. Iets wat voor mij onbereikbaar leek, kwam steeds dichterbij. Daarnaast heb ik 
onze tocht naar de top van de Kilimanjaro, zo vlak voor de eindsprint, als zeer bijzonder 
ervaren. Het gaf me de rust en het vertrouwen dat het laatste stuk ook zou lukken. 
Floris, jij ook bedankt dat je zo’n leuke broer bent en altijd voor je kleine zusje klaar 
staat. Nadat we allebei zijn gaan studeren, hebben we afwisselend op kortere of langere 
afstand van elkaar gewoond, maar voor onze band heeft dat nooit uitgemaakt. Ik vind het 
geweldig dat je uit India over komt om je kleine zusje bij te staan op 7 april.
David, jou wil ik tot slot bedanken voor je begrip en acceptatie van mijn ambities.  
Gelukkig heb je een groot sociaal netwerk en heb je besloten om halverwege mijn 
promotie zelf een tweejarige master-studie te volgen. Daardoor hebben we de laatste 
maanden niet veel kwantiteit, maar gelukkig wel kwaliteit samen gehad. Hoewel de dag 
van mijn verdediging steeds dichterbij komt en het einde van de drukte in zicht lijkt,  
ben ik bang dat ik altijd op zoek blijf naar nieuwe uitdagingen. Gelukkig weet jij op 
subtiele wijze mijn balans in evenwicht te houden. Daarvoor heel veel dank.
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